Draft Water Quality Criteria Methodology Revisions: Human Health
Federal RegisterAug 14, 1998
Ask Donna
What actually matters in this document.
Text
SUMMARY: EPA is announcing the availability for public comment of draft
revisions to the Methodology for Deriving Ambient Water Quality
Criteria for the Protection of Human Health (``AWQC Methodology
Revisions'') published pursuant to Section 304(a)(1) of the Clean Water
Act (CWA). These AWQC Methodology Revisions, once finalized, will
supersede the existing Guidelines and Methodology Used in the
Preparation of Health Effect Assessment Chapters of the Consent Decree
Water Criteria Documents (``1980 AWQC National Guidelines''), published
by EPA in November 1980 (45 FR 79347, Appendix C). Today's document is
intended to satisfy the requirements of Section 304(a)(1) of the CWA
that EPA periodically revise criteria for water quality to accurately
reflect the latest scientific knowledge on the kind and extent of all
identifiable effects on health and welfare that may be expected from
the presence of pollutants in any body of water, including ground
water. These AWQC Methodology Revisions are necessitated by the many
significant scientific advances that have occurred during the past 17
years in such key areas as cancer and noncancer risk assessments,
exposure assessments, and bioaccumulation. These revisions are not
regulations and do not impose legally-binding requirements on EPA,
States, Territories, Tribes, or the public. Also published as part of
this document are draft AWQC criteria document summaries for three
contaminants that reflect the Draft AWQC Methodology Revisions.
AVAILABILITY OF DOCUMENTS: The Draft AWQC Methodology Revisions are
published below. Copies of the technical support document and the three
complete criteria documents cited in this document may be obtained from
the U.S. EPA National Center for Environmental Publications and
Information (NCEPI), 11029 Kenwood Road, Cincinnati, OH 45242 or (513)
489-8190. Materials in the public docket will be available for public
inspection and copying during normal business hours at the Office of
Water Docket, 401 M St., S.W., Washington, D.C. 20460 by appointment
only. Appointments may be made by calling (202) 260-3027 and requesting
item W-97-20. A reasonable fee will be charged for photocopies.
Selected documents supporting the Draft AWQC Methodology Revisions
will also be available for viewing by the public at the following
locations:
I. Region 1 Library, JFK Federal Building, One Congress Street, Boston,
MA 02203 (617) 565-3300
II. Region 2 Library, 290 Broadway, 16th Floor, New York, NY 10007
(212) 637-3185
III. Region 3 Library, 841 Chestnut Building, Philadelphia, PA 19107
(215) 566-5254
IV. Region 4 Library, Atlanta Federal Center, 61 Forsyth St, SW, 9th
Floor Tower, Atlanta, GA 30303-3104 (404) 347-4216
V. Region 5 Library, 77 West Jackson Boulevard, Chicago, IL 60604-3590
(312) 353-2022
VI. Region 6 Library, 1445 Ross Avenue, Dallas, TX 75202 (214) 665-6424
VII. Region 7 Information Resource Center, 726 Minnesota Avenue, Kansas
City, KS 66101-2728 (913) 551-7241
VIII. Region 8 Library, 999 18th Street, Suite 500, Denver, CO 80202-
2466 (303) 312-6746
IX. Region 9 Library, 75 Hawthorne Street, San Francisco, CA 94105
(415) 744-1517
X. Region 10 Library, 1200 Sixth Avenue, Seattle, WA 98101 (206) 553-
1289
DATES: EPA will accept public comments on the Draft AWQC Methodology
Revisions on or before December 14, 1998. Comments postmarked after
this date may not be considered.
ADDRESSES: An original and three copies of all comments and enclosures,
including references, on the draft AWQC Methodology Revisions should be
addressed to the W-97-20 Docket Clerk, Water Docket (4101), U.S. EPA,
401 M St., S.W., Washington, D.C. 20460. Electronic comments must be
submitted as a WordPerfect 5.1 or WP 6.1 file or as an ASCII file
avoiding the use of special characters. Comments and data will also be
accepted on disks in WordPerfect 5.1 or WP 6.1 or ASCII file format.
Electronic comments on this document may be filed via e-mail at: ow-
[email protected]. Commenters who want EPA to acknowledge receipt
of their comments should include a self-addressed stamped envelope. No
facsimiles (faxes) will be accepted.
FOR FURTHER INFORMATION CONTACT: Denis Borum (4304), U.S. EPA, 401 M
St. S.W., Washington, D.C. 20460 (Telephone: (202) 260-8996).
SUPPLEMENTARY INFORMATION:
List of Acronyms Used
ADI Acceptable Daily Intake.
ARAR Applicable or Relevant and
Appropriate Requirements.
ASTM American Society of Testing and
Materials.
AWQC Ambient Water Quality Criteria.
BAF Bioaccumulation Factor.
BCF Bioconcentration Factor.
BMD Benchmark Dose.
BMR Benchmark Response.
BSAF Biota-Sediment Accumulation
Factors.
BW Body Weight.
C18 Carbon-18
CDC U.S. Centers for Disease Control
and Prevention.
CR Consumption Rate.
CSFII Continuing Survey of Food Intake
by Individuals.
CTR California Toxics Rule.
CWA Clean Water Act.
DI Drinking Water Intake.
DNA Deoxyribonucleic Acid.
DOC Dissolved Organic Carbon.
DT Non-Fish Dietary Intake.
ED10 Dose Associated with a 10
Percent Extra Risk.
EMAP Environmental Modeling and
Assessment Program.
EPA Environmental Protection Agency.
FCM Food Chain Multiplier.
FDA Food and Drug Administration.
FEL Frank Effect Level.
FI Fish Intake.
FIFRA Federal Insecticide, Fungicide,
and Rodenticide Act.
FR Federal Register.
FSTRAC Federal State Toxicology and
Risk Analysis Committee.
GI Gastrointestinal.
GLI Great Lakes Water Quality
Initiative.
IARC International Agency for
Research on Cancer.
II Incidental Intake.
ILSI International Life Sciences
Institute.
IN Inhalation Intake.
IRIS Integration Risk Information
System.
kg kilogram
Kow Octanol-Water Partition
Coefficient.
L Liter.
LED10 The Lower 95 Percent Confidence
Limit on a Dose Associated with
a 10 Percent Extra Risk.
[[Page 43757]]
LMS Linear Multistage Model.
LOAEL Lowest Observed Adverse Effect
Level.
LR Lifetime Risk.
MCL Maximum Contaminant Level.
MCLG Maximum Contaminant Level Goal.
MF Modifying Factor.
mg Milligrams.
ml Milliliters.
MoA Mode of Action.
MoE Margin of Exposure.
MoS Margin of Safety.
NCHS National Center for Health
Statistics.
NHANES National Health and Nutrition
Examination Survey.
NIEHS National Institute of
Environmental Health Sciences.
NOAEL No Observed Adverse Effect
Level.
NOEL No Observed Effect Level.
NPDES National Pollutant Discharge
Elimination System.
NTIS National Technical Information
Service.
NTR National Toxics Rule.
ODES Ocean Data Evaluation System.
PAH Polycyclic Aromatic Hydrocarbon.
PBPK Physiologically Based
Pharmacokinetic.
PCB Polychlorinated BIPHENYLS.
PCS Permits Compliance System.
Pdp Point of Departure.
POC Particulate Organic Carbon.
q1* Cancer Potency Factors.
RDA Recommended Daily Allowance.
RfC Reference Concentration.
RfD Reference Dose.
RPF Relative Potency Factor.
RSC Relative Source Contribution.
RSD Risk Specific Dose.
SAR Structure-Activity Relationship.
SAB Science Advisory Board.
SDWA Safe Drinking Water Act.
SF Safety Factor.
STORET Storage Retrieval.
TCDD-dioxin Tetrachlorodibenzo-p-dioxin.
TEAM Total Exposure Assessment
Methodology.
TEF Toxicity Equivalency Factor.
TMDL Total Maximum Daily Load.
TSD Technical Support Document.
USDA United States Department of
Agriculture.
UF Uncertainty Factor.
WQBEL Water Quality-Based Effluent
Limits.
Table of Contents
Summary of Today's Action
Appendix I. Background
A. Water Quality Criteria and Standards
1. Water Quality Criteria and the Criteria Derivation
Methodology
2. Summary of the 1980 AWQC National Guidelines
3. Water Quality Standards
B. Need for Revision of the 1980 AWQC National Guidelines
1. Scientific Advances Since 1980
2. EPA Human Health Risk Assessment Guidelines Development Since
1980
3. Differing Risk Assessment and Risk Management Approaches for
AWQC and MCLGs
C. Steps Taken toward Evaluating and Revising the 1980 AWQC
National Guidelines
1. September 1992 National Workshop
2. Science Advisory Board Review
3. FSTRAC Review
4. Water Quality Guidance for the Great Lakes System
D. Overview of AWQC Methodology Revisions, Major Changes, and
Issues
E. Risk Characterization Considerations
1. Background
2. Additional Guiding Principles
3. Risk Characterization Applied to the Revised AWQC Methodology
4. Science, Science Policy, and Risk Management
5. Discussion of Uncertainty
(a) Observed Range of Toxicity Versus Range of Environmental
Exposure
(b) Continuum of Preferred Data/Use of Defaults
(c) Significant Figures
Appendix II. Implementation of AWQC Methodology Revisions
A. Relationship to Other EPA Activities
B. Status of Existing 304(a) Criteria for Priority Pollutants
and Methodology
C. State and Tribal Criteria Development
D. Process for Developing New or Revised 304(a) Criteria
E. Development of Future Criteria Documents
F. Prioritization Scheme for Selecting Chemicals for Updating
G. Request for Comments
Appendix III. Elements of Methodology Revisions and Issues by
Technical Area
A. Cancer Effects
1. Background on EPA Cancer Assessment Guidelines
(a) 1980 AWQC National Guidelines
(b) 1986 EPA Guidelines for Carcinogenic Risk Assessment
(c) Scientific Issues Associated with the Current Cancer Risk
Assessment Methodology for the Development of AWQC
2. Proposed Revisions to EPA's Carcinogen Risk Assessment
Guidelines
3. Revised Carcinogen Risk Assessment Methodology for Deriving
AWQC
(a) Weight-of-Evidence Narrative
(b) Dose Estimation
(1) Determining the Human Equivalent Dose
(2) Dose Adjustments for Less-than-Lifetime Exposure Periods
(3) Dose-Response Analysis
(c) Characterizing Dose-Response Relationships in the Range of
Observation
(1) Extrapolation to Low, Environmentally Relevant Doses
(2) Biologically Based Modeling Approaches
(3) Default Linear Extrapolation Approach
(4) Default Nonlinear Approach
(5) Both Linear and Nonlinear Approaches
(d) AWQC Calculation
(e) Risk Characterization
(f) Use of Toxicity Equivalence Factors (TEF) and Relative
Potency Estimates
4. Request for Comments
References for Cancer Effects
B. Noncancer Effects
1. 1980 AWQC National Guidelines for Noncancer Effects
2. Noncancer Risk Assessment Developments Since 1980
3. Issues and Recommendations Concerning the Derivation of AWQC
for Noncarcinogens
(a) Using the Current NOAEL-UF Based RfD Approach or Adopting
More Quantitative Approaches for Noncancer Risk Assessment
(1) The Benchmark Dose
(2) Categorical Regression
(3) Summary
(b) Presenting the RfD as a Single Point or as a Range for
Deriving AWQC
(c) Guidelines to be Adopted for Derivation of Noncancer Health
Effects Values
(d) Treatment of Uncertainty Factors/Severity of Effects During
the RfD Derivation and Verification Process
(e) Use of Less-Than-90-Day Studies to Derive RfDs
(f) Use of Reproductive/Developmental, Immunotoxicity, and
Neurotoxicity Data as the Basis for Deriving RfDs
(g) Applicability of Physiologically Based Pharmacokinetic
(PBPK) Data in Risk Assessment
(h) Consideration of Linearity (or Lack of a Threshold) for
Noncarcinogenic Chemicals
(i) Minimum Data Requirements
4. SAB Comments
5. Request for Comments
References for Noncancer Effects
C. Exposure
1. Policy Issues
(a) Identifying the Population Subgroup that the AWQC Should
Protect
(b) Appropriateness of Including the Drinking Water Pathway in
AWQC
(c) Relationship Between Human Health AWQC and Drinking Water
Standards
(d) Setting Separate AWQC for Drinking Water and Fish
Consumption
(e) Incidental Ingestion from Ambient Surface Waters
2. Consideration of Nonwater Sources of Exposure When Setting
AWQC
(a) Background
(b) Exposure Decision Tree Approach
(c) Quantification of Exposure
(d) Inclusion of Inhalation and Dermal Exposures From Household
Drinking Water Uses
(e) Inclusion of Inhalation Exposures in RSC Analysis
[[Page 43758]]
(f) Bioavailability of Substances from Different Routes of
Exposure
(g) Consideration of Non-water Exposure Procedures for
Noncarcinogens, Linear Carcinogens, and Nonlinear Carcinogens
3. Factors Used in the AWQC Computation
(a) Human Body Weight Values for Dose Calculations
(1) Rate Protective of Human Health from Chronic Exposure
(2) Rates Protective of Developmental Human Health Effects
(3) Rates Based on Combining Intake and Body Weight
(b) Drinking Water Intake Rates
(1) Rate Protective of Human Health from Chronic Exposure
(2) Rates Protective of Developmental Human Health Effects
(3) Rates Based on Combining Drinking Water Intake and Body
Weight
(c) Incidental Ingestion from Ambient Surface Waters
(d) Fish Intake Rates
(1) Rates Protective of Human Health from Chronic Exposure
(2) Rates Protective of Developmental Human Health Effects
(3) Rates Based on Combining Fish Intake and Body Weight
4. Request for Comments
References for Exposure
D. Bioaccumulation
1. Introduction
2. Bioaccumulation and Bioconcentration Concepts
3. Existing EPA Guidance
4. Definitions
5. Determining Bioaccumulation Factors for Nonpolar Organic
Chemicals
6. Estimating Baseline BAFs
(a) Field-Measured Baseline BAF
(b) Baseline BAF Derived from BSAFs
(c) Calculation of a Baseline BAF from a Laboratory-Measured BCF
and FCM
(d) Calculation of a Baseline BAF from a Kow and FCM
(e) Metabolism
7. BAFs Used in Deriving AWQC
8. Inorganic Substances
9. SAB Comments
10. Issues for Public Comment
References for Bioaccumulation
E. Microbiology
1. Existing Microbiological Criteria
2. Plans for Future Work
3. SAB Comments
References for Microbiology
F. Other Considerations
1. Minimum Data Considerations
2. Site-Specific Criterion Calculation
3. Organoleptic Criteria
4. Criteria for Chemical Classes
5. Criteria for Essential Elements
Appendix IV. Summary of Ambient Water Quality Criteria for the
Protection of Human Health: Acrylonitrile
Appendix V. Summary of Ambient Water Quality Criteria for the
Protection of Human Health: 1,3-Dichloropropene
Appendix VI. Summary of Ambient Water Quality Criteria for the
Protection of Human Health: Hexachlorobutadiene
Summary of Today's Action
I. Background
Section 304(a)(1) of the Clean Water Act requires EPA to develop
and periodically revise criteria for water quality accurately
reflecting the latest scientific knowledge. In 1980, EPA published
ambient water quality criteria (AWQC) for 64 pollutants/pollutant
classes and provided a methodology for deriving the criteria. The 1980
AWQC National Guidelines for developing human health AWQC addressed
three types of endpoints: noncancer, cancer and organoleptic (taste and
odor) effects. Criteria values for the protection against noncancer and
cancer effects were estimated by using risk assessment-based
procedures, including extrapolation from animal toxicity or human
epidemiological studies. Basic human exposure assumptions were applied
to the criterion equation, such as: the exposed individual is a 70-
kilogram adult male; the assumed consumption of freshwater and
estuarine fish and shellfish is 6.5 grams/day; and the assumed
ingestion rate of drinking water is 2 liters/day. When using cancer as
the critical risk assessment endpoint, which was assumed not to have a
threshold, the AWQC were presented for information purposes as a range
of concentrations associated with specified incremental lifetime risk
levels (i.e., a range from 10-5 to 10-7). When
using noncancer effects as the critical endpoint, the AWQC reflected an
assessment of a ``no-effect'' level, since noncancer effects generally
exhibit a threshold.
Scientific Advances Since 1980
Since 1980, EPA risk assessment practices have evolved
significantly, particularly in the areas of cancer and noncancer risk
assessments, exposure assessments and bioaccumulation. In cancer risk
assessment, there have been advances with respect to the use of mode of
action information to support both the identification of carcinogens
and the selection of procedures to characterize risk at low,
environmentally relevant exposure levels. Related to this is the
development of new procedures to quantify cancer risks at low doses to
replace the current default use of the linearized multistage (LMS)
model. In noncancer risk assessment, the Agency is moving toward the
use of the benchmark dose (BMD) and other dose-response approaches in
place of the traditional NOAEL approach to estimate a reference dose or
concentration. In exposure analysis, several new studies have addressed
water consumption and fish tissue consumption. These exposure studies
provide a more current and comprehensive description of national,
regional and special population consumption patterns that EPA has
reflected in the Draft AWQC Methodology Revisions. In addition, more
formalized procedures are now available to account for human exposure
to multiple sources when setting health goals such as AWQC that have
addressed only one exposure source. With respect to bioaccumulation,
the Agency has moved toward the use of a bioaccumulation factor (BAF)
to reflect the uptake of a contaminant from all sources (e.g.,
ingestion, sediment) by fish and shellfish, rather than just from the
water column as reflected by the use of a bioconcentration factor (BCF)
as included in the 1980 methodology. The Agency has developed detailed
procedures and guidelines for estimating BAF values.
EPA Human Health Risk Assessment Guidelines Developed Since 1980
When the 1980 AWQC National Guidelines were developed, EPA had not
yet developed formal cancer or noncancer risk assessment guidelines.
Since then EPA has published several risk assessment guidelines
documents. In 1996, the Agency published Proposed Guidelines for
Carcinogen Risk Assessment (61 FR 17960) which when finalized will
supersede the carcinogenic risk assessment guidelines published in 1986
(51 FR 33992). In addition, guidelines for mutagenicity assessment were
also published in 1986 (51 FR 34006). The Agency also issued guidelines
for assessing the health risks to chemical mixtures in 1986 (51 FR
34014). With respect to noncancer risk assessment, the Agency published
guidelines in 1988 for assessing male and female reproductive risk (53
FR 24834) and in 1991 for assessing developmental toxicity (56 FR
63798). The guidelines for assessing reproductive toxicity were
subsequently updated and finalized (61 FR 56274) in 1996. In 1991, the
Agency also developed an external review draft of revised risk
assessment guidelines for noncancer health effects. In 1995, EPA also
proposed guidelines for neurotoxicity risk assessment (60 FR 52032).
In addition to these risk assessment guidelines, EPA also published
the ``Exposure Factors Handbook'' in 1989, which presents commonly used
Agency exposure assumptions and the surveys from which they are
derived. The Exposure Factors Handbook (EPA/600/P-95/002Fa) was updated
in 1997. In 1992, EPA published the revised
[[Page 43759]]
Guidelines for Exposure Assessment (57 FR 22888), which describe
general concepts of exposure assessment, including definitions and
associated units, and provide guidance on planning and conducting an
exposure assessment. Also, in the 1980s the Agency published the Total
Exposure Assessment Methodology (TEAM), which presents a process for
conducting comprehensive evaluation of human exposures. The Agency has
recently developed the Relative Source Contribution Policy, which is
currently undergoing Agency review, for assessing total human exposure
to a contaminant and allocating the RfD among the media of concern. In
1997, EPA developed draft Guiding Principles for Monte Carlo analysis.
Also, in 1986, the Agency made available to the public the
Integrated Risk Information System (IRIS). IRIS is a data base that
contains risk information on the cancer and noncancer effects of
chemicals. The IRIS assessments are peer reviewed and represent EPA
consensus positions across the Agency's program offices and regional
offices. In 1995, the Agency initiated an IRIS pilot program to test
improvements to the internal peer review and consensus processes, and
to provide more integrated characterizations of cancer and noncancer
health effects.
Differing Risk Assessment and Risk Management Approaches for AWQC and
MCLGs
Another reason for these revisions is the need to bridge the gap
between the differences in the risk assessment and risk management
approaches used by EPA's Office of Water for the derivation of AWQC
under the authority of the CWA and MCLGs (Maximum Contaminant Level
Goals) under the Safe Drinking Water Act (SDWA). Three notable
differences are with respect to the treatment of chemicals designated
as Group C possible human carcinogens--under the 1986 Guidelines for
Carcinogen Risk Assessment, the consideration of nonwater sources of
exposure when setting an AWQC or MCLG for a noncarcinogen, and cancer
risk ranges.
1. Group C Chemicals. Chemicals have been typically classified as
Group C--i.e., possible human carcinogens'--under the existing (1986)
EPA cancer classification scheme for any of the following reasons:
(1) Carcinogenicity has been documented in only one test species
and/or only one cancer bioassay and the results do not meet the
requirements of ``sufficient evidence.''
(2) Tumor response is of marginal significance due to inadequate
design or reporting.
(3) Benign, but not malignant, tumors occur with an agent showing
no response in a variety of short-term tests for mutagenicity.
(4) There are responses of marginal statistical significance in a
tissue known to have a high or variable background rate.
The 1986 Guidelines for Carcinogen Risk Assessment specifically
recognized the need for flexibility with respect to quantifying the
risk of Group C agents. The guidelines noted that agents judged to be
in Group C, possible human carcinogens, may generally be regarded as
suitable for quantitative risk assessment, but that case-by-case
judgments may be made in this regard.
The EPA Office of Water has historically treated Group C chemicals
differently under the CWA and the SDWA. It is important to note that
the 1980 AWQC National Guidelines for setting AWQC under the CWA
predated EPA's carcinogen classification system, which was proposed in
1984 (49 FR 46294) and finalized in 1986 (51 FR 33992). The 1980 AWQC
National Guidelines did not explicitly differentiate among agents with
respect to the weight-of-evidence for characterizing them as likely to
be carcinogenic to humans. For all pollutants judged as having adequate
data for quantifying carcinogenic risk--including those now classified
as Group C--AWQC were derived based on data on cancer incidence. In the
November 1980 Federal Register document, EPA emphasized that the AWQC
for carcinogens should state that the recommended concentration for
maximum protection of human health is zero. At the same time, the
criteria published for specific carcinogens presented water
concentrations for these pollutants corresponding to individual
lifetime cancer risk levels in the range of 10-7 to
10-5.
In the development of national primary drinking water regulations
under the SDWA, EPA is required to promulgate a health-based MCLG for
each contaminant. The Agency policy has been to set the MCLG at zero
for chemicals with strong evidence of carcinogenicity associated with
exposure from water. For chemicals with limited evidence of
carcinogenicity, including many Group C agents, the MCLG is usually
obtained using an RfD based on its noncancer effects with the
application of an additional uncertainty factor of 1 to 10 to account
for its possible carcinogenicity. If valid noncancer data for a Group C
agent are not available to establish an RfD but adequate data are
available to quantify the cancer risk, then the MCLG is based upon a
nominal lifetime excess cancer risk calculation in the range of
10-5 to 10-6 (ranging from one case in a
population of one hundred thousand to one case in a population of one
million). Even in those cases where the RfD approach has been used for
the derivation of the MCLG for a Group C agent, the drinking water
concentrations associated with excess cancer risks in the range of
10-5 to 10-6 were also provided for comparison.
It should also be noted that EPA's pesticides program has applied
both of the previously described methods for addressing Group C
chemicals in actions taken under the Federal Insecticide, Fungicide,
and Rodenticide Act (FIFRA) and finds both methods applicable on a
case-by-case basis. Unlike the drinking water program, however, the
pesticides program does not add an extra uncertainty factor to account
for potential carcinogenicity when using the RfD approach.
2. Consideration of Nonwater Sources of Exposure. The 1980 AWQC
National Guidelines for setting AWQC recommended that contributions
from nonwater sources, namely air and non-fish dietary intake, be
subtracted from the ADI, thus reducing the amount of the ADI
``available'' for water-related sources of intake. In practice,
however, when calculating human health criteria, these other exposures
were generally not considered because reliable data on these exposure
pathways were not available. Consequently, the AWQC were usually
derived such that drinking water and fish ingestion accounted for the
entire ADI (now called RfD).
In the drinking water program, a similar ``subtraction'' method was
used in the derivation of MCLGs proposed and promulgated in drinking
water regulations through the mid-1980s. More recently, the drinking
water program has consistently used a ``percentage'' method in the
derivation of MCLGs for noncarcinogens. In this approach, the
percentage of total exposure typically accounted for by drinking water,
referred to as the relative source contribution (RSC), is applied to
the RfD to determine the maximum amount of the RfD ``allocated'' to
drinking water reflected by the MCLG value. In using this percentage
procedure, the drinking water program also applies a ceiling level of
80 percent of the RfD and a floor level of 20 percent of the RfD. That
is, the MCLG cannot account for more than 80 percent of the RfD, nor
less than 20 percent of the RfD.
[[Page 43760]]
The drinking water program usually takes a conservative public
health approach of applying an RSC factor of 20 percent to the RfD when
adequate exposure data do not exist, assuming that the major portion
(80 percent) of the total exposure comes from other sources, such as
diet.
3. Cancer Risk Ranges. In addition to the different risk assessment
approaches discussed above for deriving AWQC and MCLGs for Group C
agents, different risk management approaches have arisen between the
drinking water and ambient surface water programs with respect to using
lifetime excess risk values when setting health-based criteria for
carcinogens. As indicated previously, the surface water program
historically derived AWQC for carcinogens that generally corresponded
to lifetime excess cancer risk levels of 10-7 to
10-5. The drinking water program has set MCLGs for Group C
agents based on a slightly less stringent risk range of 10-6
to 10-5, while MCLGs for chemicals with strong evidence of
carcinogenicity (that is, classified as Group A (known) or B (probable)
human carcinogen) are set at zero.
It is also important to note that under the drinking water program,
for those substances having an MCLG of zero, enforceable Maximum
Contaminant Levels (MCLs) have generally been promulgated to correspond
with cancer risk levels ranging from 10-6 to
10-4. Unlike AWQC and MCLGs which are strictly health-based
criteria, MCLs are developed with consideration given to the costs and
technological feasibility of reducing contaminant levels in water to
meet those standards.
Steps Taken Toward Evaluating and Revising the 1980 AWQC National
Guidelines
In order to begin developing a ``state-of-the-science'' approach to
revising the 1980 AWQC National Guidelines, EPA prepared an issues
paper that described the 1980 methodology, discussed areas that needed
strengthening, and proposed revisions. This paper was then distributed
for review and comment to experts at EPA headquarters, regional
offices, and laboratories; other Federal Agencies, such as the Food and
Drug Administration (FDA), the National Institute of Environmental
Health Sciences (NIEHS), and the Centers for Disease Control and
Prevention (CDC); State health organizations; Canadian health agencies;
academe; and environmental, industry, and consulting organizations.
1. September 1992 National Workshop. On September 13-16, 1992, more
than 100 invited participants discussed the critical issues in a
workshop convened in Bethesda, Maryland. Based on their expertise,
attendees were assigned to specific technical work groups. The work
group topics were cancer risk, noncancer risk, exposure, microbiology,
minimum data, and bioaccumulation. Each work group member received a
set of detailed questions that served to focus discussions on critical
factors in the 1980 AWQC National Guidelines. After the work group
members deliberated separately on their specific technical areas, all
workshop participants were given the opportunity to comment on the
proceedings. After the workshop concluded, the chairperson for each
technical work group prepared a written summary of that group's
deliberations and recommendations. Each work group participant was
given the opportunity to review and comment on the summaries; these
comments were used to prepare a draft of the proposed revision to the
methodology.
2. Science Advisory Board Review. After review of the draft of the
proposed revisions to the methodology by EPA, the workshop
participants, and other relevant parties, a summary document was
submitted for review and comment to the Science Advisory Board (SAB) in
January 1993 and presented to the Drinking Water Committee of the SAB
during its meeting on February 8-9, 1993. The SAB presented its
official comments to EPA on August 12, 1993. The SAB comments have been
highlighted and addressed in each of the technical areas discussed in
Appendix III of this document. A complete copy of the document
submitted to the SAB and SAB's comments are available in the docket
accompanying this document.
3. FSTRAC Review. At the Federal State Toxicology and Risk Analysis
Committee (FSTRAC) meeting on December 1-3, 1993, in Washington, D.C.,
several State representatives presented their opinions on the
preliminary draft recommendations for revisions to the 1980 AWQC
National Guidelines. A summary of this meeting is presented in a
document entitled ``Workshop Summary: State Comments on the Preliminary
Draft Revisions of the Methodology for Deriving National Ambient Water
Quality Criteria for the Protection of Human Health.'' This document is
also available for review in the docket supporting this proposal.
4. Water Quality Guidance for the Great Lakes System. In March
1995, EPA published the Final Water Quality Guidance for the Great
Lakes System (60 FR 15366). The Great Lakes Water Quality Guidance,
developed under Section 118(c)(2) of the CWA, provides water quality
criteria for 29 pollutants as well as methodologies, policies, and
procedures for Great Lakes States and Tribes to establish consistent,
long-term protection for fish and shellfish in the Great Lakes and
their tributaries, as well as for the people and wildlife who consume
them. In developing the methodology to derive human health criteria for
the waters of the Great Lakes System, the Agency was mindful of the
need for consistency with the planned changes in the methodology for
deriving national AWQC for the protection of human health presented in
today's proposal. Throughout the following text, references are made to
comparisons of the two methodologies, national and Great Lakes Water
Quality Guidance, especially whenever differences occur due to regional
exposure assumptions made for the Great Lakes System.
Major Changes in the Draft AWQC Methodology Revisions
The proposal presents several changes from the 1980 AWQC National
Guidelines:
1. EPA's future role in developing AWQC for the protection of human
health will include the refinement of the revised methodology, the
development of revised criteria for chemicals of high priority and
national importance (including, but not limited to chemicals that
bioaccumulate, such as PCBs, dioxin, and mercury), and the development
or revision of AWQC for some additional priority chemicals. EPA does
not plan to completely revise all of the criteria developed in 1980 or
those updated as part of the proposed California Toxics Rule (CTR) 62
FR 42160, August 5, 1997. (This rule proposes for California, numeric
water quality criteria for priority toxic pollutants necessary to
fulfill the requirements of Section 303(c)(2)(b) of the CWA.) Further,
EPA intends to revise 304(a) criteria on the basis of one or more
components (e.g., BAF, fish intake, toxicological assessment) rather
than a full set of components. Appendix II of the FR document discusses
how the Agency is proposing to implement the methodology and revise the
304(a) criteria. EPA also discusses the role of 304(a) criteria in
State/Tribal adoption of water quality standards under Section 303(c)
of the CWA, EPA's responsibilities in reviewing and approving State/
Tribal standards, and EPA's duties in regards to promulgating State/
Tribal standards when necessary.
2. EPA encourages States and Tribes to use the revised methodology,
once finalized, to develop or revise AWQC to
[[Page 43761]]
appropriately reflect local conditions. EPA believes that AWQC
inherently require several risk management decisions that are, in many
cases, better made at the State and Tribal level (e.g., fish
consumption rates, target risk levels). EPA will continue to develop
and update necessary toxicological and exposure data needed in the
derivation of AWQC that may not be practical for the States or Tribes
to obtain. EPA encourages States and Tribes to use local or regional
fish consumption data when available.
3. The equations for deriving AWQC include toxicological and
exposure assessment parameters which are derived from scientific
analysis, science policy, and risk management decisions. For example,
parameters such as a field-measured BAF or a point of departure from an
animal study (in the form of a LOAEL/NOAEL/LED10) are
scientific values which are empirically measured, whereas the decision
to use animal effects as a surrogate for human effects involves
judgment on the part of the EPA (and similarly, by other agencies) as
to the best practice to follow when human data are lacking. Such a
decision is, therefore, a matter of science policy. On the other hand,
the choice of default fish consumption rates for protection of a
certain percentage of the general population, is clearly a risk
management decision. In many cases, the Agency has selected parameters
using its best judgment regarding the overall protection afforded by
the resulting AWQC when all parameters are combined. Appendix I
discusses in detail the differences between science, science policy,
and risk management. Appendix I also provides further details with
regard to risk characterization as related to this methodology, with
emphasis placed on explaining the uncertainties in the overall risk
assessment.
4. The Draft AWQC Methodology Revisions provide an alternative to
expressing AWQC as a water concentration. AWQC may also be expressed in
terms of a fish tissue concentration. For some substances, particularly
those that are expected to exhibit substantial bioaccumulation, the
AWQC derived using the above equations may have extremely low values,
possibly below the practical limits for detecting and quantifying the
substance in the water column. It may, therefore, be more practical and
meaningful in these cases to focus on the concentration of those
substances in fish tissue, since fish ingestion would be the
predominant source of exposure for substances that bioaccumulate.
5. EPA is proposing an incidental water ingestion exposure rate of
0.01 L/day to account for long-term incidental recreational ingestion
(i.e., swimming, boating, fishing) for use in those cases where AWQC
are developed for recreational waters that are not used as drinking
water sources.
6. AWQC for the protection of human health are designed to minimize
the risk of adverse effects occurring to humans from chronic (lifetime)
exposure to substances through the ingestion of drinking water and
consumption of fish obtained from surface waters. The Agency is not
recommending the development of additional water quality criteria
similar to the ``drinking water health advisories'' that focus on acute
or short-term effects, since these are not seen routinely as having a
meaningful role in the water quality criteria and standards program.
However, there may be some instances where the consideration of
short-term toxicity and exposure in the derivation of AWQC is
warranted. Although the AWQC are based on chronic health effects data
(both cancer and noncancer effects), the criteria are intended to also
be protective with respect to adverse effects that may reasonably be
expected to occur as a result of elevated short-term exposures. That
is, through the use of conservative assumptions with respect to both
toxicity and exposure parameters, the resulting AWQC values should
provide adequate protection not only for the general population over a
lifetime of exposure, but also for special subpopulations who, because
of high water- or fish-intake rates, or because of biological
sensitivities, have an increased risk of receiving a dose that would
elicit adverse effects from short-term exposures. The Agency
recognizes, however, that there may be some cases where the AWQC values
based on chronic toxicity may not provide adequate protection for a
subpopulation at special risk from such exposures. The Agency
encourages States, Tribes, and others employing the proposed
methodology to give consideration to such circumstances in deriving
criteria to ensure that adequate protection is afforded to all
identifiable subpopulations. (Appendix III discusses this in greater
detail.)
7. For noncarcinogens, risk managers may select another value
within an RfD range rather than the default point estimate RfD value,
in criteria development, where a rationale for the range and the value
selected can be provided. General guidance for the use of values within
the RfD range is provided based on the overall uncertainty associated
with the RfD and when adverse health effects in children are not the
basis for the RfD. For example, if the IRIS RfD is 1 mg/kg/day and the
uncertainty factor (UF) is 1,000, a log-symmetrical order of magnitude
around 1 mg/kg/day could be used resulting in a range of 0.3 to 3 mg/
kg/day. If the UF were less than 1,000, the overall range would be
reduced accordingly (e.g., \1/2\ log for UFs between 100 and 1,000; and
no range for UFs of 100 or less). However, EPA would select the point
estimate as a default (the midpoint within the range) when calculating
a 304(a) criteria value for the purposes of promulgating State or
Tribal water quality standards.
8. The Draft AWQC Methodology Revisions reflect EPA's 1996 Proposed
Guidelines for Carcinogen Risk Assessment. For instance, mode of action
(MoA) information is used to determine the most appropriate low-dose
extrapolation approach for carcinogenic agents. The dose-response
assessment under the new guidelines is a two-step process. In the first
step, the response data are modeled in the range of empirical
observation. Modeling in the observed range is done with biologically
based or appropriate curve-fitting modeling. In the second step,
extrapolation below the range of observation is accomplished by
biologically based modeling if there are sufficient data or by a
default procedure (linear, nonlinear, or both). A point of departure
for extrapolation is estimated from modeling observed data. The lower
95 percent confidence limit on a dose associated with 10 percent extra
risk (i.e., LED10) is proposed as a standard point of
departure for low-dose extrapolation. If it is determined that the MoA
understanding supports a nonlinear extrapolation, the AWQC is derived
using the nonlinear default which is based on a margin of exposure
(MoE) analysis for the point of departure (e.g., the LED10)
and applying a safety factor(s) in the risk management. The linear
default would be considered for those agents that are better supported
by the assumption of linearity (e.g., direct DNA reactive mutagens) for
their MoA. A linear approach would also be applied when inadequate or
no information is available to explain the carcinogenic MoA as a
science policy choice in the interest of public health. The linear
default is a straight line extrapolation to the origin (i.e., zero
dose, zero extra risk) from the point of departure (e.g.,
LED10) identified in the observable response range. There
may be situations where it is appropriate to apply both the linear and
nonlinear
[[Page 43762]]
default procedures (e.g., for an agent that is both DNA reactive and
active as a promoter at higher doses).
9. For substances that are carcinogenic, particularly those for
which the mode of action suggests nonlinearity at low doses, the Agency
recommends that an integrated approach be taken in looking at cancer
and noncancer effects, and if one pathway does not predominate, AWQC
values should be determined for both carcinogenic and noncarcinogenic
effects. The lower of the resulting values should be used for the AWQC.
10. When deriving AWQC for noncarcinogens and nonlinear
carcinogens, a factor must be included to account for other nonwater
exposure sources so that the entire RfD, or [Point of Departure (Pdp)
divided by a safety factor (SF); (Pdp)/SF)] is not allocated to
drinking water and fish consumption alone. Guidance is provided in the
revised methodology for determining the factor, referred to as the
relative source contribution (RSC), to be used for a particular
chemical. The Agency is proposing the use of a decision tree procedure
to support the determination of the appropriate RSC value for a given
water contaminant. In the absence of data, the Agency will use 20
percent of the RfD as the default RSC in calculating a 304(a) criteria
value for the purposes of promulgating State or Tribal water quality
standards.
11. When deriving AWQC for linear carcinogens, the Agency
recommends that risk levels in the range of 10-5 to
10-6 be used for the protection of the general population.
States and Tribes can always choose a more stringent risk level, such
as 10-7. Care should be taken, however, in situations where
the AWQC includes fish intake levels based on the general population to
ensure that the risk to more highly exposed subgroups (sportfishers or
subsistence fishers) does not exceed the 10-4 level.
12. The default fish consumption values are 17.80 grams/day for the
general population, which represents the 90th percentile consumption
rate for the entire population (and approximates the average
consumption rate for sport anglers, nationally) and 86.30 grams/day for
subsistence fishers/minority anglers, which represents the 99th
percentile consumption rate for the general population and is within
the range of average intakes for subsistence fishers/minority anglers
(comments are requested on alternatively using 39.04 grams/day for
subsistence fishers/minority anglers, which is lower in the range of
averages). These values are derived from the United States Department
of Agriculture's (USDA) Continuing Survey of Food Intake by Individuals
(CSFII) from 1989-1991. These rates replace the single default value of
6.5 grams/day used in the 1980 AWQC National Guidelines. These default
values are chosen to be protective of the majority of the individuals
in those groups. However, States and Tribes are urged to use a fish
intake level derived from local data on fish consumption in place of
these default values when deriving AWQC, ensuring that the fish intake
level chosen be protective of highly exposed individuals in the
population. Consumption rates for women of childbearing age and
children younger than 14 are also provided to maximize protection in
those cases where these subpopulations may be at greatest risk.
13. All criteria should be derived using a BAF rather than a BCF,
which was used in the 1980 AWQC National Guidelines. The BAF should be
developed using the EPA methodology or any method consistent with the
EPA method. EPA's highest preference in developing BAFs are BAFs based
on field-measured data from local/regional fish.
14. EPA is neither setting organoleptic criteria nor a default
methodology for deriving such criteria. Such criteria will necessitate
case-by-case analysis.
The attached document includes six major sections: Appendix I,
which discusses the purpose of the methodology, the background
associated with the original methodology and the need for revision, and
the major changes in the revised methodology; Appendix II, which
addresses implementation issues associated with the methodology;
Appendix III, which presents the main scientific areas that make up the
methodology (cancer, noncancer, exposure, and bioaccumulation methods);
and Appendices IV through VI, which present summaries of the three
criteria developed for inclusion with the revised methodology. Complete
versions of the three criteria documents are available on the Internet
at http://www.epa.gov/OST/Rules/index.html#open.
This document proposes revisions to EPA's 1980 methodology for the
development of water quality criteria to protect human health. The
revisions reflect scientific advancements since 1980 in a number of
areas, including cancer and noncancer risk assessments, exposure
assessments and bioaccumulation. When final, the revised methodology
will provide guidance to States, Tribes, and the public on the approach
that EPA expects to take in developing recommended human health
criteria. The revised methodology also will provide guidance to States
and Tribes that they may use in developing human health criteria as
part of their water quality standards; States and Tribes use such
standards in implementing a number of environmental programs, including
setting discharge limits in NPDES permits. The revised methodology does
not substitute for the Clean Water Act or EPA's regulations; nor is it
a regulation itself. Thus, the revised methodology cannot impose
legally-binding requirements on EPA, States, or the public, and may not
apply to a particular situation based upon the circumstances. EPA and
State decisionmakers retain the discretion to use different,
scientifically defensible, methodologies to develop human health
criteria. EPA may change the methodology in the future.
This criteria methodology incorporates scientific advancements made
over the past two decades. The use of this methodology is an important
component of the Agency's efforts to improve the quality of the
Nation's waters. EPA believes the methodology will enhance the overall
scientific basis of water quality criteria. Further, the methodology
should help States and Tribes address their unique water quality issues
and risk management decisions, and afford them greater flexibility in
developing their water quality programs.
Dated: August 3, 1998.
J. Charles Fox,
Acting Assistant Administrator for Water.
Appendix I. Background
A. Water Quality Criteria and Standards
1. Water Quality Criteria and the Criteria Derivation Methodology
EPA published the availability of ambient water quality criteria
(AWQC) documents for 64 toxic pollutants and pollutant categories
identified in Section 307(a) of the Clean Water Act (CWA) in the
Federal Register on November 28, 1980 (45 FR 79318). The November 1980
Federal Register document also summarized the criteria documents and
discussed in detail the methods used to derive the AWQC for those
pollutants. The AWQC for those 64 pollutants and pollutant categories
were published pursuant to Section 304(a)(1) of the CWA:
``The Administrator, * * * shall develop and publish, * * *,
(and from time to time thereafter revise) criteria for water quality
accurately reflecting the latest scientific knowledge (A) on the
kind and extent of all identifiable effects on health and welfare
including, but not limited to, plankton, fish, shellfish, wildlife,
plant life, shorelines,
[[Page 43763]]
beaches, esthetics, and recreation which may be expected from the
presence of pollutants in any body of water, including ground water;
(B) on the concentration and dispersal of pollutants, or their
byproducts, through biological, physical, and chemical processes;
and (C) on the effects of pollutants on the biological community
diversity, productivity, and stability, including information on the
factors affecting rates of eutrophication and rates of organic and
inorganic sedimentation for varying types of receiving waters.''
The AWQC published in November 1980 provided two essential types of
information: (1) discussions of available scientific data on the
effects of the pollutants on public health and welfare, aquatic life,
and recreation; and (2) quantitative concentrations or qualitative
assessments of the levels of pollutants in water which, if not
exceeded, will generally ensure adequate water quality for a specified
water use. Water quality criteria developed under Section 304(a) are
based solely on data and scientific judgments on the relationship
between pollutant concentrations and environmental and human health
effects. The 304(a) criteria do not reflect consideration of economic
impacts or the technological feasibility of meeting the chemical
concentrations in ambient water. As discussed below, 304(a) criteria
may be used as guidance by States and Tribes to establish water quality
standards, which ultimately provide a basis for controlling discharges
or releases of pollutants.
The 1980 AWQC were derived using guidelines and methodologies
developed by the Agency for calculating the impact of waterborne
pollutants on aquatic organisms and on human health. Those guidelines
and methodologies consisted of systematic procedures for assessing
valid and appropriate data concerning a pollutant's acute and chronic
adverse effects on aquatic organisms, nonhuman mammals, and humans. The
guidelines and methodologies were fully described in Appendix B (for
protection of aquatic life and its uses) and Appendix C (for protection
of human health) of the November 1980 Federal Register document.
This revised methodology addresses the development of AWQC to
protect human health; a similar process to revise the methodology for
deriving AWQC for the protection of aquatic life is currently underway
at the Agency. When finalized, the Agency intends to use the revised
AWQC human health methodology to both develop new AWQC for additional
chemicals and to revise existing AWQC. Appendices IV-VI are summaries
of criteria developed using the revised methodology. These AWQC were
developed to demonstrate the different risk assessment and exposure
approaches presented in the revised methodology. The complete criteria
documents are available from NTIS or on EPA's Internet web site. In
addition, EPA intends to derive AWQC for the protection of human health
for several chemicals of high priority, including but not limited to,
PCBs, lead, mercury, arsenic, and dioxin, within the next several
years. EPA anticipates that the focus of 304(a) criteria development
will be criteria for bioaccumulative chemicals and chemicals considered
highest priority by the Agency. The Draft AWQC Methodology Revisions
presented here are also intended to provide States and Tribes
flexibility in setting water quality standards by providing
scientifically valid options for developing their own water quality
criteria that consider local conditions. States and Tribes are
encouraged to use the methodology once it is finalized to derive their
own AWQC. However, the revised methodology also defines the default
factors EPA intends to use in evaluating and determining consistency of
State water quality standards with the requirements of the CWA. The
Agency intends to use these default factors to calculate water quality
criteria when promulgating water quality standards for a State or Tribe
under Section 303(c) of the Act.
2. Summary of the 1980 AWQC National Guidelines
The 1980 AWQC National Guidelines for developing AWQC for the
protection of human health addressed three types of endpoints:
noncancer, cancer, and organoleptic (taste and odor) effects. Criteria
values for protection against noncancer and cancer effects were
estimated by using risk assessment-based procedures, including
extrapolation from animal toxicity or human epidemiological studies.
Basic human exposure assumptions were applied, such as: the exposed
individual is a 70-kilogram adult male; the assumed consumption of
freshwater and estuarine fish and shellfish is 6.5 grams per day; and
the assumed ingestion rate of drinking water is 2 liters per day.
When using cancer as the critical risk assessment endpoint, which
has been assumed not to have a threshold, the AWQC were presented as a
range of concentrations associated with specified incremental lifetime
risk levels 1 (i.e., a range from 10-5 to
10-7). When using noncancer effects as the endpoint, the
AWQC reflected an assessment of a ``no-effect'' level, since noncancer
effects generally exhibit a threshold. The risk assessment-based
procedures used to derive the AWQC to protect human health were
specific to whether the endpoint was cancer or noncancer. The key
features of each procedure are described briefly in the following
sections.
---------------------------------------------------------------------------
\1\ Throughout this document, the term ``risk level'' regarding
a cancer assessment endpoint specifically refers to an upper-bound
estimate of excess lifetime cancer risk.
---------------------------------------------------------------------------
Cancer effects. If human or animal studies on a contaminant
indicated that it induced a statistically significant carcinogenic
response, the 1980 AWQC National Guidelines treated the contaminant as
a carcinogen and derived a low-dose cancer potency factor from
available animal data using the linearized multistage model (LMS). The
LMS, which uses a linear, nonthreshold assumption for low-dose risk,
was used by the Agency as a science policy choice in protecting public
health, and represents the most plausible upper limit for low-dose
risk. The cancer potency factor, which expresses incremental, lifetime
risk as a function of the rate of intake of the contaminant, was then
combined with exposure assumptions to express that risk in terms of an
ambient water concentration. In the 1980 AWQC National Guidelines, the
Agency presented a range of contaminant concentrations corresponding to
incremental cancer risks of 10-7 to 10-5 (that
is, a risk of one additional case of cancer in a population of ten
million to one additional cancer case in a population of one hundred
thousand, respectively). The risk range was presented for information
purposes and did not represent an Agency judgment on ``acceptable''
risk level. The Agency stated in 1980 that: ``for the maximum
protection of human health from the potential carcinogenic effects due
to exposure of Chemical X through ingestion of contaminated water and
aquatic organisms, the ambient water concentration should be zero based
on the nonthreshold assumption for this chemical. However, zero level
may not be attainable at the present time. Therefore, the levels which
may result in incremental cancer risk over the lifetime are estimated
at 10-5, 10-6, and 10-7.''
Noncancer effects. If the pollutant was not considered to have the
potential for causing cancer in humans (this was later defined as a
known, probable, or possible human carcinogen by the 1986 Guidelines
for Cancer Risk), the 1980 AWQC National Guidelines treated the
contaminant as a noncarcinogen, and a criterion was derived using a
threshold
[[Page 43764]]
concentration for noncancer adverse effects. The criteria derived from
noncancer data were based on the Acceptable Daily Intake (ADI) (now
termed the reference dose [RfD]). ADI values were generally derived
using no-observed- adverse-effect level (NOAEL) data from animal
studies, although human data were used whenever available. The ADI was
calculated by dividing the NOAEL by an uncertainty factor to account
for uncertainties inherent in extrapolating toxicological data from
animal studies to humans. In accordance with the National Research
Council recommendations of 1977, safety factors (later termed
uncertainty factors) of 10, 100, or 1,000 were used, depending on the
quality and quantity of the data.
Organoleptic effects. Organoleptic characteristics were also used
in developing criteria for some contaminants to control undesirable
taste and/or odor imparted by them to ambient water. In some cases, a
water quality criterion based on organoleptic effects would be more
stringent than a criterion based on toxicologic endpoints. The 1980
AWQC National Guidelines emphasized that criteria derived for
organoleptic endpoints are not based on toxicologic information, have
no direct relationship to adverse human health effects and, therefore,
do not necessarily represent approximations of acceptable risk levels
for humans.
3. Water Quality Standards
Under Section 303 of the CWA, States have the primary
responsibility to establish water quality standards, defined under the
Act as designated beneficial uses of a water segment and the water
quality criteria necessary to support those uses. Additionally, Native
American Tribes authorized to administer the water quality standards
program under 40 CFR 131.8 establish water quality standards for waters
within their jurisdictions. This statutory framework allows States and
Tribes to work with local communities to establish appropriate
designated uses, and adopt criteria to protect those designated uses.
Section 303 provides for EPA review of Water Quality Standards and for
promulgation of a superseding Federal rule in cases where State or
Tribal standards are not consistent with the applicable requirements of
the CWA, or in situations where the Agency determines Federal standards
are necessary to meet the requirements of the Act. Section 303(c)(2)(B)
specifically requires States and Tribes to adopt AWQC for toxics for
which EPA has published criteria under Section 304(a), and for which
the discharge or presence could reasonably be expected to interfere
with the designated use adopted by the State or Tribe. In adopting such
criteria, States and Tribes must establish numerical values based on
one of the following: (1) 304(a) criteria; (2) 304(a) criteria modified
to reflect site-specific conditions; or, (3) other scientifically
defensible methods.
In order to avoid confusion, it must be recognized that the Act
uses the term ``criteria'' in two separate ways. In Section 303(c), the
term is part of the definition of a water quality standard. That is, a
water quality standard is composed of designated uses and the criteria
necessary to protect those uses. Thus, States and Tribes are required
to adopt regulations which contain legally enforceable criteria.
However, in Section 304(a) the term criteria is used to describe the
scientific information that EPA develops to be used as guidance in the
State, Tribal, or Federal adoption of water quality standards pursuant
to 303(c). Thus, two distinct purposes are served by the
304(a)criteria. The first is as guidance to the States and Tribes in
the development and adoption of water quality criteria which will
protect designated uses, and the second is as the basis for
promulgation of a superseding Federal rule when such action is
necessary.
B. Need for Revision of the 1980 AWQC National Guidelines
l. Scientific Advances Since 1980
Since 1980, EPA risk assessment practices have evolved
significantly, particularly in the areas of cancer and noncancer risk
assessments, exposure assessments, and bioaccumulation. In cancer risk
assessment, there have been advances with respect to the use of mode of
action information to support both the identification of carcinogens
and the selection of procedures to characterize risk at low,
environmentally relevant exposure levels. Related to this is the
development of new procedures to quantify cancer risk at low doses to
replace the current default use of the LMS model. (See discussion in
Appendix III, Section A.) In noncancer risk assessment, the Agency is
moving toward the use of the benchmark dose (BMD) and other dose-
response approaches in place of the traditional NOAEL approach to
estimate a reference dose or concentration. A BMD is calculated by
fitting a mathematical dose-response model to data using appropriate
statistical procedures. (See discussion in Appendix III, Section B.)
In exposure analysis, several new studies have addressed water
consumption and fish-tissue consumption. These studies provide a more
current and comprehensive description of national, regional, and
special-population consumption patterns that EPA has reflected in the
Draft AWQC Methodology Revisions presented today. In addition, more
formalized procedures are now available to account for human exposure
from multiple sources when setting health goals such as AWQC that
address only one exposure source. (See discussion in Appendix III,
Section C.)
With respect to bioaccumulation, the Agency has moved toward the
use of a bioaccumulation factor (BAF) to reflect the uptake of a
contaminant from all sources (e.g., ingestion, sediment) by fish and
shellfish, rather than just from the water column as reflected by the
use of a bioconcentration factor (BCF) as included in the 1980
methodology. The Agency has also developed detailed procedures and
guidelines for estimating BAF values. (See discussion in Appendix III,
Section D.)
2. EPA Human Health Risk Assessment Guidelines Development Since 1980
When the 1980 AWQC methodology was developed, EPA had not yet
developed formal cancer or noncancer risk assessment guidelines. Since
then EPA has published several risk assessment guidelines documents. In
1996, the Agency proposed revised guidelines for carcinogenic risk
assessment (61 FR 17960) which when finalized will supersede the
carcinogenic risk assessment guidelines published in 1986 (51 FR
33992). In addition, guidelines for mutagenicity assessment were also
published in 1986 (51 FR 34006). The Agency also issued guidelines for
assessing the health risks to chemical mixtures in 1986 (51 FR 34014).
With respect to noncancer risk assessment, the Agency published
guidelines in 1988 for assessing male and female reproductive risk (53
FR 24834) and in 1991 for assessing developmental toxicity (56 FR
63798). The guidelines for assessing reproductive toxicity were
subsequently updated and finalized (61 FR 56274) in 1996. In 1991, the
Agency also developed an external review draft of revised risk
assessment guidelines for noncancer health effects. In 1995, EPA also
proposed guidelines for neurotoxicity risk assessment (60 FR 52032).
In addition to these risk assessment guidelines, EPA also published
the
[[Page 43765]]
``Exposure Factors Handbook'' in 1989, which presents commonly used
Agency exposure assumptions and the surveys from which they are
derived. The Exposure Factors Handbook (EPA/600/P-95/002Fa) was updated
in 1997. In 1992 EPA published the revised Guidelines for Exposure
Assessment (57 FR 22888), which describe general concepts of exposure
assessment, including definitions and associated units, and provide
guidance on planning and conducting an exposure assessment. Also, in
the 1980s the Agency published the Total Exposure Assessment
Methodology (TEAM), which presents a process for conducting
comprehensive evaluation of human exposures. The Agency has recently
developed the Relative Source Contribution Policy, which is currently
undergoing Agency review, for assessing total human exposure to a
contaminant and allocating the RfD among the media of concern. In 1997,
EPA developed draft Guiding Principles for Monte Carlo analysis.
Also, in 1986, the Agency made available to the public the
Integrated Risk Information System (IRIS). IRIS is a data base that
contains risk information on the cancer and noncancer effects of
chemicals. The IRIS assessments are peer reviewed and represent EPA
consensus positions across the Agency's program and regional offices.
In 1995, the Agency initiated an IRIS pilot program to test
improvements to the internal peer review and consensus processes, and
to provide more integrated characterizations of cancer and noncancer
health effects.
3. Differing Risk Assessment and Risk Management Approaches for AWQC
and MCLGs
There are some differences in the risk assessment and risk
management approaches used by EPA's Office of Water for the derivation
of AWQC under the authority of the CWA and MCLGs (Maximum Contaminant
Level Goals) under the Safe Drinking Water Act (SDWA). Two notable
differences are with respect to the treatment of chemicals designated
as Group C possible human carcinogens under the 1986 Guidelines for
Carcinogen Risk Assessment and the consideration of nonwater sources of
exposure when setting an AWQC or MCLG for a noncarcinogen.
Group C Chemicals. Chemicals have been typically classified as
Group C--i.e., possible human carcinogens--under the existing (1986)
EPA cancer classification scheme for any of the following reasons:
1. Carcinogenicity has been documented in only one test species
and/or only one cancer bioassay and the results do not meet the
requirements of ``sufficient evidence.''
2. Tumor response is of marginal significance due to inadequate
design or reporting.
3. Benign, but not malignant, tumors occur with an agent showing no
response in a variety of short-term tests for mutagenicity.
4. There are responses of marginal statistical significance in a
tissue known to have a high or variable background rate.
The 1986 Guidelines for Carcinogen Risk Assessment specifically
recognized the need for flexibility with respect to quantifying the
risk of Group C agents. The guidelines noted that agents judged to be
in Group C, possible human carcinogens, may generally be regarded as
suitable for quantitative risk assessment, but that case-by-case
judgments may be made in this regard.
The EPA Office of Water has historically treated Group C chemicals
differently under the CWA and the SDWA. It is important to note that
the 1980 AWQC National Guidelines for setting AWQC under the CWA
predated EPA's carcinogen classification system, which was proposed in
1984 (49 FR 46294) and finalized in 1986 (51 FR 33992). The 1980 AWQC
National Guidelines did not explicitly differentiate among agents with
respect to the weight-of-evidence for characterizing them as likely to
be carcinogenic to humans. For all pollutants judged as having adequate
data for quantifying carcinogenic risk--including those now classified
as Group C--AWQC were derived based on data on cancer incidence. In the
November 1980 Federal Register document, EPA emphasized that the AWQC
for carcinogens should state that the recommended concentration for
maximum protection of human health is zero. At the same time, the
criteria published for specific carcinogens presented water
concentrations for these pollutants corresponding to individual
lifetime cancer risk levels in the range of 10-7 to
10-5.
In the development of national primary drinking water regulations
under the SDWA, EPA is required to promulgate a health-based MCLG for
each contaminant. The Agency policy has been to set the MCLG at zero
for chemicals with strong evidence of carcinogenicity associated with
exposure from water. For chemicals with limited evidence of
carcinogenicity, including many Group C agents, the MCLG is usually
obtained using an RfD based on its noncancer effects with the
application of an additional uncertainty factor of 1 to 10 to account
for its possible carcinogenicity. If valid noncancer data for a Group C
agent are not available to establish an RfD but adequate data are
available to quantify the cancer risk, then the MCLG is based upon a
nominal lifetime excess cancer risk calculation in the range of
10-5 to 10-6 (ranging from one case in a
population of one hundred thousand to one case in a population of one
million). Even in those cases where the RfD approach has been used for
the derivation of the MCLG for a Group C agent, the drinking water
concentrations associated with excess cancer risks in the range of
10-5 to 10-6 were also provided for comparison.
It should also be noted that EPA's pesticides program has applied
both of the previously described methods for addressing Group C
chemicals in actions taken under the Federal Insecticide, Fungicide,
and Rodenticide Act (FIFRA) and finds both methods applicable on a
case-by-case basis. Unlike the drinking water program, however, the
pesticides program does not add an extra uncertainty factor to account
for potential carcinogenicity when using the RfD approach.
Consideration of Nonwater Sources of Exposure. The 1980 AWQC
National Guidelines for setting AWQC recommended the use of the
following equation to derive the criterion:
[GRAPHIC] [TIFF OMITTED] TN14AU98.000
where:
C=The criterion value
ADI=Acceptable daily intake (mg/kg-day)
DT=Non-fish dietary intake (mg/kg-day)
IN=Inhalation intake (mg/kg-day)
2=Assumed daily water intake (L/day)
0.0065=Assumed daily fish consumption (kg)
R=Bioconcentration factor (L/kg)
As implied by this equation, the contributions from nonwater
sources, namely air and non-fish dietary intake, were to be subtracted
from the ADI, thus reducing the amount of the ADI ``available'' for
water-related sources of intake. In practice, however, when calculating
human health criteria, these other exposures were generally not
considered because reliable data on these exposure pathways were not
available. Consequently, the AWQC were usually derived such that
drinking water and fish ingestion accounted for the entire ADI (now
called RfD).
In the drinking water program, a similar ``subtraction'' method was
used
[[Page 43766]]
in the derivation of MCLGs proposed and promulgated in drinking water
regulations through the mid-1980s. More recently, the drinking water
program has consistently used a ``percentage'' method in the derivation
of MCLGs for noncarcinogens. In this approach, the percentage of total
exposure typically accounted for by drinking water, referred to as the
relative source contribution (RSC), is applied to the RfD to determine
the maximum amount of the RfD ``allocated'' to drinking water reflected
by the MCLG value. In using this percentage procedure, the drinking
water program also applies a ceiling level of 80 percent of the RfD and
a floor level of 20 percent of the RfD. That is, the MCLG cannot
account for more than 80 percent of the RfD, nor less than 20 percent
of the RfD.
The drinking water program usually takes a conservative public
health approach of applying an RSC factor of 20 percent to the RfD when
adequate exposure data do not exist, assuming that the major portion
(80 percent) of the total exposure comes from other sources, such as
diet.
Cancer Risk Ranges. In addition to the different risk assessment
approaches discussed above for deriving AWQC and MCLGs for Group C
agents, different risk management approaches have arisen between the
drinking water and ambient surface water programs with respect to using
lifetime excess risk values when setting health-based criteria for
carcinogens. As indicated previously, the surface water program has
derived AWQC for carcinogens that generally correspond to lifetime
excess cancer risk levels of 10-7 to 10-5. The
drinking water program has set MCLGs for Group C agents based on a
slightly less stringent risk range of 10-6 to
10-5, while MCLGs for chemicals with strong evidence of
carcinogenicity (that is, classified as Group A, known, or B probable,
human carcinogen) are set at zero.
It is also important to note that under the drinking water program,
for those substances having an MCLG of zero, enforceable Maximum
Contaminant Levels (MCLs) have generally been promulgated to correspond
with cancer risk levels ranging from 10-6 to
10-4. Unlike AWQC and MCLGs which are strictly health-based
criteria, MCLs are developed with consideration given to the costs and
technological feasibility of reducing contaminant levels in water to
meet those standards.
C. Steps Taken Toward Evaluating and Revising the 1980 AWQC National
Guidelines
In order to begin developing a ``state-of-the-science'' approach to
revising the 1980 AWQC National Guidelines, EPA prepared an issues
paper that described the 1980 methodology, discussed areas that needed
strengthening, and proposed revisions. This paper was then distributed
for review and comment to experts at EPA headquarters, regional
offices, and laboratories; other Federal Agencies, such as the Food and
Drug Administration (FDA), the National Institute of Environmental
Health Sciences (NIEHS), and the Centers for Disease Control and
Prevention (CDC); State health organizations; Canadian health agencies;
academe; and environmental, industry, and consulting organizations.
1. September 1992 National Workshop
On September 13-16, 1992, more than 100 invited participants
discussed the critical issues in a workshop convened in Bethesda,
Maryland. Based on their expertise, attendees were assigned to specific
technical work groups. The work group topics were cancer risk,
noncancer risk, exposure, microbiology, minimum data, and
bioaccumulation. Each work group member received a set of detailed
questions that served to focus discussions on critical factors in the
1980 AWQC National Guidelines. After the work group members deliberated
separately on their specific technical areas, all workshop participants
were given the opportunity to comment on the proceedings. After the
workshop concluded, the chairperson for each technical work group
prepared a written summary of that group's deliberations and
recommendations. Each work group participant was given the opportunity
to review and comment on the summaries; these comments were used to
prepare an initial draft of the revised methodology.
2. Science Advisory Board Review
After review of the initial draft of the revisions to the
methodology by EPA, the workshop participants, and other relevant
parties, a summary document was submitted for review and comment to the
Science Advisory Board (SAB) in January 1993 and presented to the
Drinking Water Committee of the SAB during its meeting on February 8-9,
1993. The SAB presented its official comments to EPA on August 12,
1993. The SAB comments have been highlighted and addressed in each of
the technical areas discussed in Appendix III of this document. A
complete copy of the document submitted to the SAB and SAB's comments
are available in the docket supporting this Notice.
3. FSTRAC Review
At the Federal State Toxicology and Risk Analysis Committee
(FSTRAC) meeting on December 1-3, 1993, in Washington, D.C., several
State representatives presented their opinions on the initial draft
revised methodology and the SAB's comments. A summary of this meeting
is presented in a document entitled ``Summary Report: State Comments on
the Proposed Revision of the Methodology for Deriving National Ambient
Water Quality Criteria for the Protection of Human Health.'' This
document is also available for review in the docket supporting this
Notice.
4. Water Quality Guidance for the Great Lakes System
In March 1995, EPA published the Final Water Quality Guidance for
the Great Lakes System (60 FR 15366). The Great Lakes Water Quality
Guidance, developed under Section 118(c)(2) of the CWA, provides water
quality criteria for 29 pollutants as well as methodologies, policies,
and procedures for Great Lakes States and Tribes to establish
consistent, long-term protection for fish and shellfish in the Great
Lakes and their tributaries, as well as for the people and wildlife who
consume them. In developing the methodology to derive human health
criteria for the waters of the Great Lakes System, the Agency was
mindful of the need for consistency with the planned changes in the
methodology for deriving national AWQC for the protection of human
health presented today. Throughout the following text, references are
made to comparisons of the two methodologies, national and Great Lakes
Water Quality Guidance, especially whenever differences occur due to
regional exposure assumptions made for the Great Lakes System.
D. Overview of AWQC Methodology Revisions, Major Changes, and Issues
Following is a summary of the major revisions to the 1980 AWQC
National Guidelines:
1. EPA's future role in developing AWQC for the protection of human
health will include the refinement of the revised methodology, the
development of revised criteria for chemicals of high priority and
national importance (including, but not limited to chemicals that
bioaccumulate, such as PCBs, TCDD-dioxin, and mercury), and the
development or revision of AWQC for some additional priority chemicals.
EPA does not plan to completely revise all of
[[Page 43767]]
the criteria developed in 1980 or those updated as part of either the
1992 National Toxics Rule (NTR) or the 1997 proposed California Toxics
Rule (CTR). Partial updates of all criteria may be plausible. (Appendix
II discusses how the Agency is proposing to implement the methodology
and update or revise the 304(a) criteria.)
2. EPA encourages States and Tribes to use the revised methodology,
once finalized, to develop or revise AWQC to appropriately reflect
local conditions. EPA believes that AWQC inherently require several
risk management decisions that are, in many cases, better made at the
State, Tribal, and local level (e.g., fish consumption rates, target
risk levels). EPA will continue to develop and update necessary
toxicological and exposure data needed to use in the derivation of AWQC
that may not be practical to obtain at the State, Tribal, or local
level. EPA encourages States and Tribes to use local or regional fish
consumption data when available.
3. The following equations for deriving AWQC include toxicological
and exposure assessment parameters which are derived from scientific
analysis, science policy, and risk management decisions. For example,
parameters such as a field-measured BAF or a point of departure from an
animal study (in the form of a LOAEL/NOAEL/LED10) are
scientific values which are empirically measured, whereas the decision
to use animal effects as a surrogate for human effects involves
judgment on the part of the EPA (and similarly, by other agencies) as
to the best practice to follow when human data are lacking. Such a
decision is, therefore, a matter of science policy. On the other hand,
the choice of default fish consumption rates for protection of a
certain percentage (in this case, 90 percent and 95 percent
respectively) of the general population, is clearly a risk management
decision. In many cases, the Agency has selected parameters using its
best judgment regarding the overall protection afforded by the
resulting AWQC when all parameters are combined. For a longer
discussion of the differences between science, science policy, and risk
management, please refer to Section E. Section E also provides further
details with regard to risk characterization as related to this
methodology, with emphasis placed on explaining the uncertainties in
the overall risk assessment.
The generalized equations for deriving AWQC based on noncancer
effects are: 2
---------------------------------------------------------------------------
\2\ The fish intake (FI) and bioaccumulation factor (BAF)
parameters are presented here in simplified form. It is preferable
to calculate criteria by splitting these out by trophic level since
bioaccumulation may vary significantly from one level to another.
This is discussed further in the bioaccumulation section and
specific guidance is given in the Technical Support Document for
this methodology. Also, the proposed example criteria that accompany
these proposed revisions use trophic level breakouts for these
parameters.
---------------------------------------------------------------------------
Noncancer Effects 3
[GRAPHIC] [TIFF OMITTED] TN14AU98.001
Nonlinear Cancer Effects
[GRAPHIC] [TIFF OMITTED] TN14AU98.002
Linear Cancer Effects
[GRAPHIC] [TIFF OMITTED] TN14AU98.003
where:
\3\ Although appearing in this equation as a factor to be
multiplied, the RSC can also be an amount subtracted. Refer to the
explanation key below the equations.
---------------------------------------------------------------------------
AWQC=Ambient Water Quality Criterion (mg/L)
RfD=Reference dose for noncancer effects (mg/kg-day)
Pdp=Point of departure for nonlinear carcinogens (mg/kg-day), usually a
LOAEL, NOAEL, or LED10
SF=Safety Factor for nonlinear carcinogens (unitless)
RSD=Risk-specific dose for linear carcinogens (mg/kg-day) (Dose
associated with a target risk, such as 10-6)
RSC=Relative source contribution factor to account for nonwater sources
of exposure. (Not used for linear carcinogens.) May be either a
percentage (multiplied) or amount subtracted, depending on whether
multiple criteria are relevant to the chemical.
BW=Human body weight (proposed default=70 kg for adults)
DI=Drinking water intake (proposed default=2 L/day for adults)
FI=Fish intake (proposed defaults=0.01780 kg/day for general adult
population and sport anglers, and 0.08630 kg/day for subsistence
fishers)
BAF=Bioaccumulation factor, lipid normalized (L/kg)
4. As an alternative to expressing AWQC as a water concentration as
provided in the above equations, AWQC may also be expressed in terms of
a fish tissue concentration. For some substances, particularly those
that are expected to exhibit substantial bioaccumulation, the AWQC
derived using the above equations may have extremely low values,
possibly below the practical limits for detecting and quantifying the
substance in the water column. It may, therefore, be more practical and
meaningful in these cases to focus on the concentration of those
substances in fish tissue, since fish ingestion would be the
predominant source of exposure for substances that bioaccumulate. Fish
tissue criteria that correspond to an AWQC expressed as a water
concentration obtained from one of the above equations is computed as
(note, the BAF used should be the same one that was used to calculate
the AWQC):
[[Page 43768]]
[GRAPHIC] [TIFF OMITTED] TN14AU98.004
5. EPA is recommending an incidental water ingestion exposure rate
of 0.01 L/day to account for long-term incidental recreational
ingestion (i.e., swimming, boating, fishing) for use in those cases
where AWQC are developed for recreational waters that are not used as
drinking water sources.
6. AWQC for the protection of human health are designed to minimize
the risk of adverse effects occurring to humans from chronic (lifetime)
exposure to substances through the ingestion of drinking water and
consumption of fish obtained from surface waters. The Agency is not
recommending the development of additional water quality criteria
similar to the ``drinking water health advisories'' that focus on acute
or short-term effects, since these are not seen routinely as having a
meaningful role in the water quality criteria and standards program.
However, as discussed below, there may be some instances where the
consideration of acute or short-term toxicity and exposure in the
derivation of AWQC is warranted.
Although the AWQC are based on chronic health effects data (both
cancer and noncancer effects), the criteria are intended to also be
protective with respect to adverse effects that may reasonably be
expected to occur as a result of elevated acute or short-term
exposures. That is, through the use of conservative assumptions with
respect to both toxicity and exposure parameters, the resulting AWQC
values should provide adequate protection not only for the general
population over a lifetime of exposure, but also for special
subpopulations who, because of high water- or fish-intake rates, or
because of biological sensitivities, have an increased risk of
receiving a dose that would elicit adverse effects. The Agency
recognizes, however, that there may be some cases where the AWQC values
based on chronic toxicity may not provide adequate protection for a
subpopulation at special risk from shorter-term exposures. The Agency
encourages States, Tribes, and others employing the revised methodology
to give consideration to such circumstances in deriving criteria to
ensure that adequate protection is afforded to all identifiable
subpopulations. (See Appendix III, Section C.3 for additional
discussion of these subpopulations.)
7. For noncarcinogens, risk managers may select an RfD range rather
than a single RfD value, in criteria development, where a rationale for
the range and the value selected can be provided. General guidance for
the use of values within the RfD range is provided based on the overall
uncertainty associated with the RfD. For example, if the IRIS RfD is 1
mg/kg/day and the uncertainty factor (UF) is 1,000, a log-symmetrical
order of magnitude (i.e., 10-fold) around 1 mg/kg/day could be used
resulting in a range of 0.3 to 3 mg/kg/day. If the UF were less than
1,000, the overall range would be reduced accordingly (i.e., \1/2\ log
(3-fold) for UFs between 100 and 1,000, resulting in a range of 0.67 to
1.5 mg/kg/day; and no range for UFs of 100 or less). However, EPA
intends to select the point estimate as a default (the midpoint within
the range) when calculating a 304(a) criteria value for the purposes of
promulgating State or Tribal water quality standards. Furthermore, an
RfD range should not be used when children are identified as the
exposed population of concern.
8. As explained in EPA's 1996 Proposed Guidelines for Carcinogen
Risk Assessment, mode of action (MoA) information is used to determine
the most appropriate low-dose extrapolation approach for carcinogenic
agents. The dose-response assessment under the new guidelines is a two-
step process. In the first step, the response data are modeled in the
range of empirical observation. Modeling in the observed range is done
with biologically based or appropriate curve-fitting modeling. In the
second step, extrapolation below the range of observation is
accomplished by biologically based modeling if there are sufficient
data or by a default procedure (linear, nonlinear, or both). A point of
departure for extrapolation is estimated from modeling observed data.
The lower 95 percent confidence limit on a dose associated with 10
percent extra risk (LED10) is proposed as a standard point
of departure for low-dose extrapolation. If it is determined that the
MoA understanding supports a nonlinear extrapolation, the AWQC is
derived using the nonlinear default which is based on a margin of
exposure (MoE) analysis for the point of departure (LED10)
and applying a margin of safety (MoS) in the risk management. The
linear default would be considered for those agents that are better
supported by the assumption of linearity (e.g., direct DNA reactive
mutagens) for their MoA. A linear approach would also be applied when
inadequate or no information is available to explain the carcinogenic
MoA as a science policy choice in the interest of public health. The
linear default is a straight line extrapolation to the origin (i.e.,
zero dose, zero extra risk) from the point of departure
(LED10) identified in the observable response range. There
may be situations where it is appropriate to apply both the linear and
nonlinear default procedures (e.g., for an agent that is both DNA
reactive and active as a promoter at higher doses).
9. For substances that are carcinogenic, particularly those for
which the mode of action suggests nonlinearity at low doses, the Agency
recommends that an integrated approach be taken in looking at cancer
and noncancer effects, and if one pathway does not predominate, AWQC
values should be determined for both carcinogenic and noncarcinogenic
effects. The lower of the resulting values should be used for the AWQC.
10. When deriving AWQC for noncarcinogens and nonlinear
carcinogens, a factor must be included to account for other nonwater
exposure sources so that the entire RfD, or [Point of Departure (Pdp)
divided by a safety factor (SF) (Pdp)/SF)] is not allocated to drinking
water and fish consumption alone. Guidance is provided in the revised
methodology for determining the factor, referred to as the RSC, to be
used for a particular chemical. The Agency is recommending the use of a
decision tree procedure to support the determination of the appropriate
RSC value for a given water contaminant. In the absence of data, the
Agency intends to use 20 percent of the RfD as the default RSC in
calculating a 304(a) criteria value for the purposes of promulgating
State or Tribal water quality standards.
11. For AWQC derived for linear carcinogens, the Agency recommends
that risk levels in the range of 10-5 to 10-6 be
used. (See RSD factor in Equation ID-3, above.) States and Tribes can
always choose a more stringent risk level, such as 10-7.
Care should be taken, however, in situations where the AWQC includes
fish intake levels based on the general population to ensure that the
risk to more highly exposed subgroups (sportfishers or subsistence
fishers) does not exceed the 10-4 level.
12. The default fish consumption values in the revised methodology
are 17.80 grams/day for the general adult population, which represents
the 90th percentile consumption rate for the entire adult population
(and approximates the average consumption
[[Page 43769]]
rate for sport anglers, nationally); and 86.30 grams/day for
subsistence fishers/minority anglers, which represents the 99th
percentile consumption rate for the general population and falls within
the range of averages for subsistence/minority anglers. Public comments
are requested on alternatively using 39.04 grams/day, which represents
the 95th percentile (and is also within the range of averages), and
which of these two values (i.e., 39.04 or 86.30 grams/day) is more
representative of fresh/estuarine fish consumption among subsistence
fishers/minority anglers. These values are derived from the United
States Department of Agriculture's (USDA) Continuing Survey of Food
Intake by Individuals (CSFII) from 1989-1991. These rates replace the
single default value of 6.5 grams/day used in the 1980 AWQC National
Guidelines. These default values are chosen to be protective of the
majority of the individuals in those groups. However, States and Tribes
are urged to use a fish intake level derived from local data on fish
consumption in place of these default values when deriving AWQC,
ensuring that the fish intake level chosen be protective of highly
exposed individuals in the population. Consumption rates for women of
childbearing age and children younger than 14 are also provided to
maximize protection in those cases where these subpopulations may be at
greatest risk.
13. In the revised methodology, criteria are derived using a BAF
rather than a BCF, which was used in the 1980 AWQC National Guidelines.
To derive the BAF, States and Tribes may use EPA's methodology or any
method consistent with the EPA method. EPA's highest preference in
developing BAFs are BAFs based on field-measured data from local/
regional fish.
14. EPA is neither setting organoleptic criteria nor recommending a
default methodology for deriving such criteria. Such criteria will
necessitate case-by-case analysis.
E. Risk Characterization Considerations
1. Background
On March 21, 1995, the EPA Administrator, Carol Browner, issued the
EPA Risk Characterization Policy and Guidance. This policy and guidance
is intended to ensure that characterization information from each stage
of a risk assessment is used in forming conclusions about risk and that
this information is communicated from risk assessors to risk managers,
and from EPA to the public. The policy also provides the basis for
greater clarity, transparency, reasonableness, and consistency in risk
assessments across EPA programs. The fundamental principles which form
the basis for a risk characterization are as follows:
Risk assessments should be transparent, in that the
conclusions drawn from the science are identified separately from
policy judgments, and the use of default values or methods and the use
of assumptions in the risk assessment are clearly articulated.
Risk characterizations should include a summary of the key
issues and conclusions of each of the other components of the risk
assessments, as well as describe the likelihood of harm. The summary
should include a description of the overall strengths and limitations
(including uncertainties) of the assessment and conclusions.
Risk characterizations should be consistent in general
format, but recognize the unique characteristics of each specific
situation.
Risk characterizations should include, at least in a
qualitative sense, a discussion of how a specific risk and its context
compares with similar risks. This may be accomplished by comparisons
with other chemicals or situations on which the Agency has decided to
act, or other situations with which the public may be familiar. The
discussion should highlight the limitations of such comparisons.
Risk characterization is a key component of risk
communication, which is an interactive process involving exchange of
information and expert opinion among individuals, groups, and
institutions.
2. Additional Guiding Principles
The risk characterization integrates the information from the
hazard identification, dose-response, and exposure assessments, using a
combination of qualitative information, quantitative information, and
information regarding uncertainties.
The risk characterization includes a discussion of
uncertainty and variability.
Well-balanced risk characterizations present conclusions and
information regarding the strengths and limitations of the assessment
for other risk assessors, EPA decision- makers, and the public.
3. Risk Characterization Applied to the Revised AWQC Methodology
In developing the methodology presented today, the EPA has closely
followed the risk characterization guiding principles listed above. As
States and Tribes develop criteria using the revised methodology, they
are strongly encouraged to follow EPA's risk characterization guidance.
There are a number of areas within the methodology and criteria
development process where risk characterization principles apply:
Integration of cancer and noncancer assessments with exposure
assessments, including bioaccumulation potential determinations, in
essence, weighing the strengths and weaknesses of the risk assessment
as a whole when developing a criterion.
Selecting a fish consumption rate, locally derived or default
value, within the context of a target population (e.g., sensitive
subpopulations) as compared to the general population.
Presenting cancer and/or noncancer risk assessment options.
Describing the uncertainty and variability in both the hazard
identification, the dose-response and the exposure assessment.
Health Risks to Children.
In recognition that children have a special vulnerability to many
toxic substances, Administrator Carol Browner directed EPA in 1995 to
explicitly and consistently take into account environmental health
risks to infants and children in all risk assessments, risk
characterizations and public health standards set for the United
States. In April 1997, President Clinton signed Executive Order 13045
on the protection of children from environmental health risks, which
assigned a high priority to addressing risks to children. In May 1997,
EPA established the Office of Children's Health Protection to ensure
the implementation of the President's Executive Order. Circumstances
where risks to children should be considered in the context of the AWQC
Methodology, along with specific recommendations, are discussed in
relevant sections throughout this proposal.
Details on risk characterization and the guiding principles stated
above are included in the March 21, 1995 policy statement and the
discussion of risk characterization which accompanies the Proposed
Guidelines for Carcinogen Risk Assessment 61 FR 17960 (April 23, 1996)
and the Reproductive and Toxicity Risk Assessment Guidelines also of
1996 (61 FR 56274).
4. Science, Science Policy, and Risk Management
An important part of risk characterization, as described at the
beginning of this Section, is to make risk assessments transparent.
This means that conclusions drawn from the science are identified
separately from policy judgments and risk management decisions, and
that the use of default
[[Page 43770]]
values or methods, as well as the use of assumptions in risk
assessments, are clearly articulated. For the purposes of this revised
methodology, EPA will attempt to separate out scientific analysis from
science policy and risk management decisions. This will ultimately
allow the States and Tribes, and specifically users of this
methodology, such as scientists, policy setters, and risk managers, to
understand the elements of the methodology accurately and clearly, and
to easily separate out the scientific decisions from the science policy
and risk management decisions. This is important so that when questions
are asked regarding the scientific merit, validity, or apparent
stringency or leniency of AWQC, the implementer of the criteria can
clearly explain what judgments were made to develop the criterion in
question and to what degree these judgments were based on science,
science policy, or risk management. To some extent this process will
also be displayed in future AWQC documents.
When EPA speaks of science or scientific analysis, we are referring
to the extraction of data from either toxicological or exposure studies
and surveys with a minimum of judgment being used to make inferences
from the available evidence. For example, if we are describing a point
of departure from an animal study (e.g., a lowest-observed-adverse-
effect level, or LOAEL), this is usually determined as a lowest dose
which produces an observable adverse effect. This would constitute a
scientific determination. Judgments applying science policy, however,
may enter this determination. For example, several scientists may
differ in their opinion of what is adverse, and this in turn can
influence the selection of a LOAEL in a given study. The use of an
animal study to predict effects in a human in the absence of human data
is an inherent science policy decision. The selection of specific
uncertainty factors when developing a reference dose is another example
of science policy. In any risk assessment, a number of decision points
occur where risk to humans can only be inferred from the available
evidence. Both scientific judgments and policy choices may be involved
in selecting from among several possible inferential bridges when
conducting a risk assessment.
Risk management is the process of weighing policy alternatives and
selecting the most appropriate regulatory action, integrating the
results of risk assessment with engineering data and with social,
economic, and political concerns to reach a decision. In this
methodology, the choice of a default fish consumption rate which is
protective of 90 percent of the general population is a risk management
decision. The choice of an acceptable cancer risk by a State or Tribe
is a risk management decision.
Many of the parameters in the revised methodology are an amalgam of
science, science policy, and/or risk management. For example, most of
the defaults chosen by EPA are based on the examination of scientific
data and the application of either science policy or risk management.
This includes the default assumptions of 2 liters a day of drinking
water; the assumption of 70 kilograms for an adult body weight; the use
of default percent lipid and particulate organic carbon/dissolved
organic carbon (POC/DOC) for developing national BAFs; the default fish
consumption rates for the general population and sport and subsistence
anglers; the choice of a default cancer risk level. Some decisions are
more heavily steeped in science and science policy, such as the choice
of default BAFs, and others are more obviously risk management
decisions, such as the determination of default fish consumption rates
and cancer risk levels. Throughout the revised methodology, EPA has
identified just what kind of decision was necessary to develop defaults
and what the basis for the decision was. More details on the concepts
of science analysis, science policy, risk management and how they are
introduced into risk assessments are included in Risk Assessment in the
Federal Government: Managing the Process, National Academy Press. 1983.
5. Discussion of Uncertainty
(a) Observed Range of Toxicity Versus Range of Environmental
Exposure. When characterizing a risk assessment, an important
distinction to make is between the observed range of adverse effects
(from an epidemiology or animal study) and the environmentally observed
range of exposure (or anticipated human exposure) to the contaminant.
In many cases, EPA intends to apply a number of default factors to
account for uncertainties or incomplete knowledge in developing RfDs or
nonlinear cancer risk assessments to provide a margin of protection. In
reality, the actual effect level and the environmental exposure levels
may be separated by several orders of magnitude. The difference between
some observed response and the anticipated human exposure should be
described by risk assessors and managers, especially when comparing
criteria to environmental levels of a contaminant.
(b) Continuum of Preferred Data/Use of Defaults. In both
toxicological and exposure assessments, EPA has defined a continuum of
preferred data ranging from a highest preference of chronic human data
for toxicological assessments (e.g., studies that examine a long-term
exposure of humans to a chemical, usually from occupational and/or
residential exposure); and actual field data for many of the exposure
decisions that need to be made (e.g., locally derived fish consumption
rates, waterbody-specific bioaccumulation rates); to default values
which are at the lower end of the preference continuum. EPA has
supplied default values for all of the risk assessment parameters in
the revised methodology; however, it is important to note that when
default values are used, the uncertainty in the final risk assessment
is usually higher, and the final resulting criterion may not be as
applicable to local conditions, than is a risk assessment derived from
human/field data. Using defaults assumes generalized conditions and may
not capture the actual variability in the population (e.g., sensitive
subpopulations/high-end consumers). If defaults are chosen as the basis
for criteria, these inherent uncertainties should be communicated to
the risk manager and the public. While this continuum is an expression
of preference on the part of EPA, it does not imply in any way that any
of the choices are unacceptable or scientifically indefensible.
(c) Significant Figures. The number of significant figures in a
numeric value is the number of certain digits plus one estimated digit.
Digits should not be confused with decimal places. For example, 15.1,
.0151, and .0150 all have 3 significant figures. Decimal places may
have been used to maintain the correct number of significant figures,
but in themselves they do not indicate significant figures (Brinker,
1984). Since the number of significant figures must include only one
estimated digit, the sources of input parameters (e.g., fish
consumption and water consumption rates) should be checked to determine
the number of significant figures associated with data they provide.
However, the original measured values may not be available to determine
the number of significant figures in the input parameters. In these
situations, EPA recommends utilizing the data as presented.
When developing criteria, EPA recommends rounding the number of
significant figures at the end of the criterion calculation to the same
number of significant figures in the least precise parameter. This is a
generally accepted
[[Page 43771]]
practice which can be found described in greater detail in APHA, 1992
and Brinker, 1984. The general rule is that for multiplication or
division, the resulting value should not possess any more significant
figures than is associated with the factor in the calculation with the
least precision. When numbers are added or subtracted, the number that
has the fewest decimal places, not necessarily the fewest significant
figures, puts the limit on the number of places that justifiably may be
carried in the sum or difference. Rounding off a number is the process
of dropping one or more digits so that the value contains only those
digits that are significant or necessary in subsequent computations
(Brinker, 1984). The following rounding procedures are recommended: (1)
if the digit 6, 7, 8, or 9 is dropped, increase the preceding digit by
one unit; (2) if the digit 0, 1, 2, 3, or 4 is dropped, do not alter
the preceding digit; and (3) if the digit 5 is dropped, round off the
preceding digit to the nearest even number (e.g., 2.25 becomes 2.2 and
2.35 becomes 2.4) (APHA, 1992 and Brinker, 1984).
EPA recommends that calculations of water quality criteria be
performed without rounding of intermediate step values. The resulting
criterion may be rounded to a manageable number of decimal places.
However, in no case should the number of digits presented exceed the
number of significant figures implied in the data and calculations
performed on them. The term ``intermediate step values'' refers to
values of the parameters in Equations ID-1 through ID-3. The final step
is considered the resulting AWQC. Although AWQC are, in turn, used for
purposes of establishing WQBELs in NPDES permits, calculating TMDLs,
and with Superfund ARARs, they are considered the final step of this
methodology and, for the purpose of this discussion, where the rounding
should occur.
The determination of appropriate significant figures inevitably
involves some judgment regarding the fact that some of the equation
parameters are adopted default exposure values. Specifically, the
default drinking water intake rate of 2 L/day is a value adopted to
represent a majority of the population over the course of a lifetime.
Although supported by drinking water consumption survey data, this
value was adopted as a policy decision and, as such, does not have to
be considered in determining the parameter with the least precision.
That is, the resulting AWQC need not always be reduced to one
significant digit. Similarly, the 70-kg adult body weight has been
adopted Agency-wide and represents a default policy decision.
The following example illustrates the rule described above. The
example is for hexachlorobutadiene (HCBD), the revised criterion
summarized in Appendix VI. The parameters that were calculated (i.e.,
not policy adopted values) include values with significant figures of
two (the Pdp and RSC), three (the SF), and four (the FI and BAF). Based
on the revised methodology, the final criterion should be rounded to
two significant figures. The bold numbers in parentheses indicate the
number of significant figures and those with asterisks also indicate
Agency adopted policy values.
[GRAPHIC] [TIFF OMITTED] TN14AU98.005
Example (refer to HCBD document for details on the data):
[GRAPHIC] [TIFF OMITTED] TN14AU98.006
* represents Agency adopted policy value.
A number of the values used in the equation may result in
intermediate step values that have more than four figures past the
decimal place and may be carried throughout the equation. However,
carrying more than four figures past the decimal place (equivalent to
the most precise parameter) is unnecessary as it has no effect on the
resulting criterion calculation.
References
APHA. American Public Health Association. 1992. Standard Methods:
For the Examination of Water and Wastewater. 18th Edition. Prepared
and published jointly by: American Public Health Association,
American Water Works Association, and Water Environment Federation.
Washington, D.C.
Brinker, R.C. 1984. Elementary Surveying. 7th Edition. Cliff
Robichaud and Robert Greiner, Eds. Harper and Row Publishers, Inc.
New York, NY.
Appendix II. Implementation of AWQC Methodology Revisions
Today's Draft AWQC Methodology Revisions raise several important
implementation issues. These include the following: (1) the
relationship of the 304(a) criteria revisions to other EPA water
quality standards activities; (2) the status of existing 304(a)
criteria once any revisions to the criteria and the associated
methodologies are finalized; (3) the role of States and Tribes in
developing the criteria; (4) the appropriateness of EPA revising 304(a)
criteria on the basis of a change in one, or fewer than all,
parameters; (5) the process EPA will utilize in developing new criteria
for additional chemicals and revising existing criteria; and (6) the
development of a priority setting process for selecting appropriate
304(a) criteria for revising. Each of these areas is discussed below.
A. Relationship to Other EPA Activities
New information leads to new insights as to how a chemical induces
a toxic effect. In response to such new information, EPA continually
updates
[[Page 43772]]
RfDs and dose-response information in IRIS. Toxicity information and
exposure assumptions change as additional data become available. This
ongoing evolution effects two important and interrelated
responsibilities of the Agency, which are carried out concurrently.
First, from time to time EPA recalculates the 304(a) water quality
criteria to reflect the latest data. These recalculations have been
compiled in a series of guidance documents: the Green Book in 1968, the
Blue Book in 1972, the Red Book in 1976, and the Gold Book in 1986. The
second responsibility pertains to the requirements of Section 303(c).
As part of the water quality standards triennial review process
defined in Section 303(c)(1), the States and Tribes are responsible for
maintaining and revising water quality standards. Section 303(c)(1)
requires States and Tribes to review, and modify if appropriate, their
water quality standards at least once every three years. When a State
or Tribe fails to revise or adopt water quality standards consistent
with the requirements of the CWA, Section 303(c)(4) authorizes EPA to
promulgate replacement water quality standards for them. From time to
time, EPA has undertaken such promulgations and calculated numeric
water quality criteria for the purposes of the Act. In doing so, EPA
utilizes the most current available scientific information, such as
toxicity data and exposure assumptions.
With the promulgation of Federal criteria under 303(c)(4) and the
publication of new or revised 304(a) criteria, the criteria in an early
Federal action may differ from the criteria in a subsequent Federal
action. Some confusion has arisen among the public with regard to what
EPA's current recommended 304(a) water quality criteria are for a given
chemical at any given time.
The most recent Federal action establishes the Agency's current
water quality criteria. To date, the most recent Federal recalculation
of 304(a) criteria occurred in the CTR, not withstanding the fact the
CTR was proposed pursuant to Section 303(c)(4) of the Act. (See
discussion below.) Again, EPA views the criteria program as constantly
evolving. When the AWQC Methodology Revisions are final, any chemical-
specific 304(a) criteria published using the revised methodology will
be considered the Agency's most current 304(a) criteria. EPA notes
revisions of existing 304(a) criteria prior to the finalization of the
revised methodology may be undertaken and are not precluded.
As discussed in Appendix I, Section B.3., States and Tribes have
three options when adopting water quality criteria for which EPA has
published 304(a) criteria. They can establish numerical values based on
304(a) criteria, 304(a) criteria modified to reflect site specific
conditions, or other scientifically defensible methods. When States or
Tribes revise their water quality criteria to correct deficiencies
identified in a Federal promulgation, EPA will assess the scientific
defensibility of the criteria in terms of the Agency's most recent
recommended water quality criteria. Thus, there may be cases where
applicable policies and science have evolved such that EPA would be
evaluating the scientific defensibility of State or Tribal criteria,
adopted using one of the three options discussed above, on the basis of
new information. Furthermore, EPA views Federal 303(c)(4) promulgations
as temporary corrections of deficiencies in State and Tribal water
quality standards. The triennial review process provides States and
Tribes with a process for addressing these deficiencies. Since CWA
Section 303(c)(1) requires States and Tribes to review and modify their
water quality standards at least once every three years, EPA does not
expect or intend to assume the State and Tribal responsibility of
periodically reviewing and revising water quality standards, including
water quality criteria, through federal promulgations.
EPA developed and published final Water Quality Guidance for the
Great Lakes System (the Guidance), codified at 40 CFR part 132, in
March 1995 (58 FR 15366). The Guidance consists of water quality
criteria for 29 pollutants to protect aquatic life, wildlife, and human
health, and detailed methodologies to develop criteria for additional
pollutants, implementation procedures, and antidegradation policies and
procedures tailored to the Great Lakes system. The Guidance was
developed using the best available science, and reflects the unique
nature of the Great Lakes ecosystem. Great Lakes States and Tribes are
to use the water quality criteria, methodologies, policies and
procedures in the Guidance to establish consistent, enforceable, long-
term protection for the waters of the Great Lakes system. Under the
CWA, the Great Lakes States are to adopt provisions into their water
quality standards and National Pollutant Discharge Elimination System
(NPDES) permit programs by March 1997 that are consistent with the
Guidance. The Guidance promotes consistency in standards and
implementation procedures while allowing appropriate flexibility to
States and Tribes to develop equitable strategies to control pollution
sources and to promote pollution prevention practices. Today's Draft
AWQC Methodology Revisions are being undertaken pursuant to Section 304
of the CWA, is independent of, and does not supersede, the Guidance.
Although consistency in State water quality standards programs is
an important goal for EPA, EPA also recognizes it is necessary to
provide appropriate flexibility to States and Tribes, both Great Lakes
States and non-Great Lakes States, in the development and
implementation of place-based water quality programs. In overseeing
States' implementation of the CWA, EPA has found that reasonable
flexibility is not only necessary to accommodate site-specific
conditions and unforseen circumstances, but also to enable innovations
and improvements as new approaches and information become available.
Recognition of a general need for flexibility is not incompatible with
the requirements for the Great Lakes States and Tribes established at
Section 118(c)(2). Once States and Tribes have adopted provisions
consistent with the Guidance, EPA intends to extend to them flexibility
in utilizing new data and information in developing and updating water
quality criteria using the Great Lakes Water Quality Guidance
methodologies. In the event a Great Lakes State or Tribe fails to adopt
provisions consistent with the Guidance, EPA will promulgate provisions
consistent with 40 CFR part 132 that will apply to waters and
discharges within that jurisdiction.
In the Draft AWQC Methodology Revisions, EPA is presenting the
acceptable lifetime cancer risk for the general population in the range
of 10-5 to 10-6 as opposed to the previous range
of 10-5 to 10-7. The Draft AWQC Methodology also
provides that States and Tribes should ensure the most highly exposed
populations do not exceed a 10-4 risk level. EPA emphasizes
selection of a risk level is a component used in the derivation of
water quality criteria, and is thus subject to EPA review under Section
303(c) of the CWA. These proposed revisions are consistent with current
program office guidance and Agency regulatory actions.
The three criteria summary documents in Appendices IV through VI
were derived using a 10-6 risk level, which the Agency
believes reflects an appropriate risk for the general population. This
risk level is already used by many States and Tribes. EPA
[[Page 43773]]
intends to continue to derive 304(a) criteria at the 10-6
risk level, applying a risk management policy which ensures protection
for all exposed population groups. EPA acknowledges that at any given
risk level for the general population, those segments of the population
that are more highly exposed face a higher relative risk. For example,
if fish are contaminated at a level permitted by criteria derived on
the basis of a risk level of 10-6, individuals consuming up
to 10 times the assumed fish consumption rate would still be protected
at a 10-5 risk level. States and Tribes have the flexibility
to adopt water quality criteria that result in a higher risk level
(e.g., 10-5). EPA expects to approve such criteria if the
State or Tribe has identified the most highly exposed subpopulation
within the State or Tribe, demonstrates the chosen risk level is
adequately protective of the most highly exposed subpopulation and has
completed all necessary public participation. EPA notes that concerns
regarding highly exposed subpopulations make it unlikely EPA would
approve a State-wide 10-4 risk level, unless it was
demonstrated that the potentially highly exposed subpopulations are, in
fact, not experiencing higher exposures than the general population. In
effect, risk for such subpopulations would not exceed a 10-4
risk level. EPA further notes that risk levels and criteria need to be
protective of tribal rights under federal law (e.g., fishing, hunting,
or gathering rights) that are related to water quality. Such rights may
raise unique issues and will need to be evaluated on a case-by-case
basis.
B. Status of Existing 304(a) Criteria for Priority Pollutants and
Methodology
In November 1980, EPA published criteria development guidelines for
the protection of human health, along with criteria for 64 toxic
pollutants and pollutant classes (45 FR 79318). The total number of
human health criteria published in 1980 was 105. Subsequently, three
volatile chemicals (dichlorodifluoromethane, trichlorofluoromethane,
and bis-(chloromethyl)-ether) were removed from the priority list. In
1984, the criteria for dioxin were published; this resulted in a total
of 103 criteria. In 1986, EPA summarized the available criteria
information in Quality Criteria for Water 1986 (1986 ``Gold Book'').
The 103 human health criteria for the protection of human health were
included in the proposed NTR in November 1991 (56 FR 58420). At that
time, 83 of the 103 criteria were revised to reflect the contemporary
IRIS values. The final NTR (codified at 40 CFR 131.36(b)(1)) included
91 human health 304(a) criteria. Nine previously published criteria
were not included in the NTR for the purposes of promulgating federal
water quality under 303(c), but remain in effect as published 304(a)
criteria. Previously published criteria for seven pollutants were
withdrawn in the NTR. The NTR directed permit authorities to
specifically address five other pollutants in NPDES permit actions
using the States' existing narrative ``free from toxicity'' criteria.
In August, 1997, EPA included revised human health criteria for 22
pollutants in the CTR (62 FR 42160). These 22 criteria, plus the
previously published 78 criteria, are the Agency's recommended human
health criteria. As such, they will continue to be used as the basis
for Agency decisions, both regulatory and nonregulatory, until EPA
revises and reissues chemical-specific criteria. For example, EPA
intends to use these criteria: (1) as guidance to States and Tribes for
use in establishing water quality standards; (2) as the basis for EPA
promulgation of water quality standards; (3) in establishing NPDES
water quality-based permit limits, where the criteria have been adopted
by a State or Tribe or promulgated by EPA; and (4) for all other
purposes of Section 304(a) criteria under the Act. It is important to
emphasize again two distinct purposes which are served by the
304(a)criteria. The first is as guidance to the States and Tribes in
the development and adoption of water quality criteria which will
protect designated uses, and the second is as the basis for
promulgation of a superseding Federal rule when such action is
necessary.
As stated above, until such time as EPA re-evaluates a chemical,
subjects the criteria to appropriate peer review, and subsequently
publishes a revised chemical-specific 304(a) criteria, the existing
304(a) criteria remain in effect. While the Draft AWQC Methodology
Revisions represent improvements to the 1980 methodology, EPA believes
the 1980 human health 304(a) criteria methodology and the resulting
criteria are fundamentally sound from a scientific standpoint. In the
Draft AWQC Methodology Revisions, EPA is presenting for public review
and comment the latest advancements in risk and exposure assessment and
the application of the most recent data available. In this manner, the
Agency will continue to strengthen the scientific and technical
foundations of the Agency's human health 304(a) criteria and provide an
incremental improvement in the level of protection afforded to the
public.
EPA has long supported this position. For example, while
undertaking reassessments of dioxin, PCBs, and other chemicals, EPA has
consistently upheld the use of the current 304(a) criteria for these
chemicals and has maintained their scientific acceptability on the
grounds that until such time as a reassessment is completed, the
existing 304(a) criteria represent EPA's best assessment for that
particular chemical.
C. State and Tribal Criteria Development
In keeping with their primary responsibility in establishing water
quality standards, EPA encourages States and Tribes to develop and
adopt water quality criteria which reflect local and regional
conditions by using the options discussed above. States and Tribes will
have access to EPA regional, laboratory, and headquarters staff when
help is needed for interpretation of the methodology revisions, and for
making critical risk assessment decisions. However, when establishing a
numerical value based on 304(a) criteria modified to reflect site
specific conditions, or on other scientifically defensible methods, EPA
strongly cautions States and Tribes not to selectively apply data in
order to ensure a water quality criteria which is less stringent than
EPA's 304(a) criteria. Such an approach would inaccurately characterize
risk in particular.
Once revisions to the human health methodology are finalized, EPA
intends to continue to update a limited number of 304(a) criteria per
year, developing the toxicological and exposure data needed to conduct
risk assessments associated with many of the toxic pollutants covered
by the current universe of 304(a) criteria. As discussed below in
Section D, updating the exposure factors used in deriving a criterion
is not as time- and resource-intensive as completing the toxicological
evaluation. EPA intends to update a limited number of 304(a) criteria
each year over the next several years using new national default
exposure assumptions, national default BAFs, and updated toxicological
values (i.e., new or revised RfDs, cancer dose-response assessments).
In establishing water quality criteria, States and Tribes are urged to
continue to use the IRIS noncancer and cancer risk assessments, but to
adjust the exposure assumptions (e.g., fish consumption and relative
source contribution) to account for local and regional conditions. If a
State- or
[[Page 43774]]
waterbody-specific exposure analysis cannot be conducted, States and
Tribes should rely on EPA national defaults.
Generally, EPA has sought to conduct re-evaluations of all of the
components of each of the 304(a) criteria before revising the criteria.
However in recent years, in recognition of both time and resource
limitations, EPA has revised existing 304(a) criteria on the basis of a
limited number of components for which there are new data or improved
science is a reasonable and efficient means to: (1) implement the
latest advances in scientific information and Agency policy for
exposure analysis; and (2) publish revised 304(a) criteria on a more
frequent basis. This approach promotes up-to-date and robust 304(a)
criteria.
Once new or revised 304(a) criteria are published by EPA, the
Agency expects States and Tribes to adopt new or revised water quality
criteria into their water quality standards consistent with the three
options discussed above. EPA believes State and Tribal adoption of up-
to-date water quality criteria for all pollutants for which EPA has
published 304(a) criteria is important for ensuring full and complete
protection of human health. EPA emphasizes it will be reviewing State
and Tribal water quality standards to assess the need for new or
revised water quality criteria. EPA believes five years from the date
of publication of new or revised 304(a) criteria is a reasonable time
frame by which States and Tribes should take action. This period is
intended to accommodate those States and Tribes which have begun a
triennial review and wish to complete the actions they have underway,
deferring initiating adoption of new or revised water quality criteria
until the next triennial review.
D. Process for Developing New or Revised 304(a) Criteria
Section 304(a)(1) directs the Agency to ``develop and publish * * *
and from time to time * * * revise criteria for water quality
accurately reflecting the latest scientific knowledge.'' Recent changes
in Agency policies and procedures, as well as potential future changes,
have implications for 304(a) criteria. These include IRIS updates, the
proposed revisions to the cancer risk assessment guidelines, and
revisions to the human health criteria methodology such as those in
today's document. Additionally, when supported by additional scientific
information, EPA has approved site-specific and chemical-specific
decisions which differ from the 304(a) criteria published in the Gold
Book. This situation, as well as the need for Federal promulgations of
water quality standards under Section 303(c)(4) discussed above, has
led to confusion among States, Tribes, and the public as to the process
for developing 304(a) criteria.
Several steps need to occur before a new 304(a) criterion for a
chemical is developed or an existing 304(a) criterion is revised.
First, new data must be evaluated by appropriate EPA Offices,
calculations of a new criterion or any revisions to existing criteria
must be completed, and any implications to other EPA programs must be
determined. EPA estimates the time to conduct risk assessment ranges
from a few months to a year or more. For exposure analyses, EPA
estimates the time to be much shorter, ranging from a few weeks to a
few months. EPA's experience is that toxicological evaluations take
longer to complete than exposure assessments due the degree and
complexity of the analysis. EPA will utilize new, relevant data in
calculating a revised criterion value without regard to whether the
revised criterion is more or less stringent. As noted above, EPA may
revise 304(a) criteria on the basis of one or more components (e.g.,
BAF, fish intake, toxicity assessment), rather than a full set of
components. This approach is in keeping with the Agency's ongoing
efforts to strengthen the scientific and technical foundations of the
304(a) criteria.
Second, EPA policy is to subject derivations of new criteria or
revisions of existing criteria to appropriate peer review. Agency peer
review consists of a documented critical review by qualified
individuals or organizations who are independent of those who
originally performed the work, but who are collectively equivalent in
technical expertise to them. Conducting peer review will help ensure
the criteria are technically adequate, appropriately derived, properly
documented and satisfy quality requirements. In addition, EPA will
accept data and information from interested members of the public
during the peer review process. Through peer review of 304(a) criteria,
EPA will provide a sound basis for its decisions, enhancing both the
credibility and acceptance of the 304(a) criteria.
Finally, EPA publishes criteria and announces their availability in
the Federal Register. While the process for developing a new 304(a)
criterion is basically the same as for revising an existing criterion,
the time and resources for developing the necessary data bases for new
criteria are significantly greater. However, the criteria development
process described above is essentially the same whether undertaken
pursuant to 304(a) or 303(c)(4).
In an effort to keep the States, Tribes, and public apprised of the
most current Agency information, EPA intends to publish on a regular
basis the current recommended 304(a) criteria, and the individual
component values used in their derivation, for guidance to States and
Tribes in adopting water quality standards under Section 303.
Traditionally, EPA has published criteria documents or summaries of
these documents (e.g., the Gold Book) as the process for incorporating
the latest scientific knowledge and updating 304(a) criteria. Under
this new approach, EPA expects to publish annually in the Federal
Register a table, similar to the one EPA publishes for the drinking
water MCLs and Health Advisories, entitled Drinking Water Regulations
and Health Advisories (EPA 822-B-96-002). The drinking water matrix
includes information on the existing MCLs, MCLGs, health advisories
including the RfD, and the cancer assessment for the chemical. The AWQC
table will contain all current recommended human health and aquatic
life 304(a) criteria values. This table will only include water quality
criteria of general national applicability. Water quality criteria
derived to address a site specific or watershed situation will not be
included. Water quality criteria from proposed or promulgated Federal
water quality standards or new or revised 304(a) criteria documents
will be regularly incorporated into the table. Additionally, for easier
public access, EPA intends to maintain this repository of current EPA
304(a) criteria and supporting information on the Internet on EPA's
home pages on the World Wide Web (www.epa.gov).
E. Development of Future Criteria Documents
The Agency intends to implement a streamlined approach to
developing criteria documents which focuses on critical toxicological
and exposure related studies. This is a departure from the past format
in which all existing toxicological and exposure studies were presented
in the 1980 criteria documents, with equal emphasis placed on exposure,
pharmacokinetics, toxicological effects, and criterion formulation. Due
to limited resources and a need to revise and update criteria more
frequently, future criteria documents will be more abbreviated, with an
emphasis on using current risk assessments (on IRIS or other EPA health
assessment documents) where available and focusing to a greater
[[Page 43775]]
extent on critical exposure and toxicological studies which may
influence the development of a 304(a) criterion (e.g., critical effects
studies which form the basis of RfD development or cancer assessment).
EPA will still review the literature for the latest studies, but does
not intend to provide an exhaustive amount of information for those
areas which are deemed less significant in the criterion development
process. Where there is a significant amount of literature on an area
of study (for instance, pharmacokinetics), EPA expects to reference the
information or cite existing IRIS support documents which discuss the
information in greater detail.
The overall objective of this change in approach is to allow EPA to
revise and update 304(a) criteria more frequently, while still
maintaining the scientific rigor which EPA requires. With this new
format, EPA estimates it can revise several criteria for the same cost
as revising a single criterion under the old format.
In Appendices IV through VI of today's document, EPA is publishing
summaries of revised criteria for three chemicals using the Draft AWQC
Methodology Revisions; the full criteria documents are available on
EPA's Internet web site at: http://www.epa.gov/OST/Rules. The three
chemicals for which criteria have been developed are: acrylonitrile,
1,3-dichloropropene, and hexachlorobutadiene.
1. Acrylonitrile
The revised criterion for protection of human health from the
consumption of drinking water and organisms is 0.055 g/L. The
criterion for the protection of human health from the consumption of
organisms and incidental ingestion of water is 4.0 g/L. These
values are based on an assumed risk level of 1 x 10-6. For
more details on assumed parameters in this calculation, see the summary
in Appendix IV of this document. The complete criteria document is
available through NTIS or on EPA's Internet web site.
2. 1,3-Dichloropropene
The revised criterion for protection of human health from the
consumption of drinking water and organisms is 0.34 g/L. The
criterion for the protection of human health from the consumption of
organisms and incidental ingestion of water is 14 g/L. These
values are based on an assumed risk level of 1 x 10-6. For
more details on assumed parameters in this calculation, see the summary
in Appendix V of this document. The complete criteria document is
available through NTIS or EPA's Internet web site.
3. Hexachlorobutadiene
The revised criteria were derived using a nonlinear (MOE) approach.
However, both linear and nonlinear approaches are demonstrated for this
chemical. Using the linear approach, the criterion for protection of
human health from the consumption of drinking water and organisms is
0.046 g/L (assumed risk level of 1 x 10-6); and the
criterion for the protection of human health from the consumption of
organisms and incidental ingestion of water is 0.049 g/L.
Using the nonlinear approach, the criterion for protection of human
health from the consumption of drinking water and organisms is 0.11
g/L; and the criterion for the protection of human health from
the consumption of organisms and incidental ingestion of water is
0.12g/L. Again, EPA recommends the nonlinear approach based on
the fact that in this specific case, there is too much uncertainty and
not enough confidence using the tumor data (only one data point at a
very high dose where the MTD has been exceeded and toxicity is severe)
to do a linear high to low dose extrapolation for the estimation of
human risk. Moreover, since data from both rats and mice support the
same NOAEL value, there is greater confidence in the data base for a
nonlinear approach. For more details on assumed parameters in this
calculation, see the summary in Appendix VI of this document. The
complete criteria document is available through NTIS or on EPA's
Internet web site.
F. Prioritization Scheme for Selecting Chemicals for Updating
As discussed above, the Agency does not have the resources to
immediately develop human health criteria, either new or revised, for
all the contaminants found in surface water. Because of this, EPA is
soliciting comment on how to prioritize chemicals for future
recommended 304(a) criteria using the revised human health methodology.
One approach for prioritizing chemicals is for EPA to publish on an
annual basis in the Federal Register a list of substances for which EPA
plans to initiate criterion development or updating. The Federal
Register document would provide the status of any ongoing criteria
updates or developments of new criteria. EPA would also ask the public
for candidates for new or updated recommended AWQC and would ask for
scientific data (either toxicological or exposure related) or a
compelling reason(s) to revise a current criterion or develop a new
AWQC. This process would be similar to that used by EPA to announce its
lists of agents for which cancer hazard and dose-response assessments
will be initiated on an annual basis (61 FR 32799). Using the
information submitted from the public and other data, the Agency would
establish a list of chemicals for which it will initiate work, on an
annual basis. EPA intends to maintain an open docket on the Internet
which would allow the public and/or interested parties to review
external submissions to the Agency for given chemicals and would also
allow an exchange of pertinent information between the public and the
Agency.
To initiate this process for prioritization, EPA evaluated
chemicals to generate a preliminary list of candidates for revision.
Focusing on chemicals that pose the greatest potential risk to human
health, the initial universe considered by EPA included the 126
priority pollutants designated as toxic under Section 307(a) of the
Act, plus seven additional pollutants included because of their
bioaccumulation potential. (EPA was required to publish criteria
documents for 65 pollutants and pollutant classes which Congress, in
the 1977 amendments to the Clean Water Act, designated as toxic under
Section 307(a)(1). The 65 pollutants and pollutant classes were, in
total, 129 chemicals which became known as the list of 129 priority
pollutants. The final number became 126 when 3 priority pollutants were
subsequently deleted.) After careful consideration, EPA identified 98
chemicals as possible candidates for new or revised 304(a) criteria.
The 98 chemicals were selected based on the following factors:
The NTR promulgated 304(a) human health criteria for 91
chemicals. EPA considers these 91 chemicals as a good representation of
the priority pollutants for which sufficient data exist to revise
304(a) criteria. (The NTR did not include human health criteria for 35
priority pollutants for the reasons discussed in the final NTR.)
Seven chemicals for which human health criteria were not
developed in the NTR but which have a high potential for
bioaccumulation, based on information contained in the recently
promulgated Great Lakes Water Quality Guidance (hexachlorocyclohexane,
mirex, octachlorostyrene, pentachlorobenzene, photomirex, 1,2,3,4-
tetrachlorobenzene, 1,2,3,5-tetrachlorobenzene).
In prioritizing the 98 chemicals discussed above, EPA considered
four factors: (1) toxicity data from IRIS; (2)
[[Page 43776]]
data on occurrence in fish tissue from The Incidence and Severity of
Sediment Contamination in Surface Waters of the United States (EPA-823-
R-97-006); (3) data on the occurrence in sediments from The Incidence
and Severity of Sediment Contamination in Surface Waters of the United
States; and (4) data on BAFs for trophic level 4 from either the
proposed or final Great Lakes Water Quality Initiative Guidance (GLWQI
or GLI). Of these four factors, EPA selected the potential for
bioaccumulation (i.e., BAFs and Log Kow) along with toxicity
(i.e., cancer slope factor or RfD) as the most indicative of potential
risk to human health. Taking these two factors into consideration, EPA
chose 29 chemicals from the list of 98 originally considered. This list
provides the initial basis for criteria revision decisions, along with
other Agency chemical ranking lists and input from States and Tribes.
Furthermore, EPA intends to use these two factors for ranking
contaminants in the future. EPA would review these priorities in light
of Agency resources and programmatic commitments when making decisions
to develop and/or revise 304(a) criteria in the future. New criterion
updates and starts would be presented in an annual Federal Register
document, as described in Section D. PCBs, mercury, and dioxin are not
on the priority list because EPA is already committed to developing
updated AWQC for these chemicals. The 29 highest ranked chemicals out
of the 98 considered (not in order of priority) are the following:
Benz(a)-Anthracene
Benzo(a)-Pyrene
4-Bromo-phenyl Phenyl-Ether
4-Chloro-phenyl Phenyl Ether
Dibenzo(a,h)Anthracene
Di-n-Butyl Phthalate
Hexachloro-benzene
Hexachloro-butadiene
Aldrin
Hexachlorocyclohexane
alpha-BHC
beta-BHC
gamma-BHC
delta-BHC
Chlordane
4,4'-DDT
4,4'-DDE
4,4'-DDD
Dieldrin
Endrin
Heptachlor
Heptachlor Epoxide
Mirex/dechlorane
Octachlorostyrene
Pentachlorobenzene
Photomirex
1,2,3,4-Tetrachlorobenzene
1,2,3,5-Tetrachlorobenzene
Toxaphene
EPA is also planning to review other prioritization efforts within
the Agency to consider possible non-bioaccumulative contaminants found
in surface water. Specifically, EPA will evaluate the Safe Drinking
Water Contaminant List and risk analyses from the Office of Pesticide
Programs.
G. Request for Comments
EPA requests comment on all aspects of the implementation strategy
and specifically requests comment on the following areas.
1. Because, as a general matter, EPA uses the cancer risk range of
10-4 to 10-6 when setting criteria and standards,
the Agency recommends a consistent approach here (i.e., 10-5
to 10-6 for the general population, while ensuring that the
most highly exposed population does not exceed a risk level of
10-4). EPA requests comment on this recommendation and its
intention to derive 304(a) criteria at the 10-6 level. Are
there other issues that the Agency should consider regarding this
policy?
2. Should EPA revise existing 304(a) criteria on the basis of a
partially updated data set (e.g., update exposure factors to be used in
calculating 304(a) criteria)?
3. With what frequency should new criteria be developed or existing
criteria updated? Is annually sufficient?
4. Does the streamlined approach to developing criteria documents
appropriately characterize the derivation of criteria using the
proposed methodology? Readers are directed to the three criteria
documents available through NTIS and EPA's Internet site as examples of
this new approach.
5. Is the list of 29 chemicals which EPA selected for
prioritization appropriate? What other chemicals should be added to the
list, and why should they be added to the list?
Appendix III. Elements of Methodology Revisions and Issues by
Technical Area
A. Cancer Effects
1. Background on EPA Cancer Assessment Guidelines
(a) 1980 AWQC National Guidelines. When EPA published the 1980 AWQC
National Guideline (USEPA, 1980), formal Agency guidelines for
assessing carcinogenic risk from exposure to chemicals had not yet been
adopted. The methodology for assessing carcinogenic risk used by EPA in
the 1980 AWQC National Guidelines is based primarily on the Interim
Procedures and Guidelines for Health Risks and Economic Impact
Assessment of Suspected Carcinogens published by EPA in 1976 (USEPA,
1976). Although the 1980 AWQC National Guidelines recommended the use
of both human epidemiological and animal studies to identify
carcinogens, potential human carcinogens were primarily identified as
those substances causing a statistically significant carcinogenic
response in animals. It was also assumed for risk assessment purposes
that any dose of the carcinogen results in some possibility of a tumor
(i.e., a nonthreshold phenomenon).
Under the 1980 guidelines, two types of data are used for
quantitative estimates: (1) lifetime animal studies; and (2) human
studies where excess cancer risk is associated with exposure to the
agent. (Human data with sufficient quantification to carry out risk
assessment are generally not available for most agents because there is
a lack of exposure data, especially for confounders.) The scaling of
doses from animals to humans uses a conversion factor of body weight to
the \2/3\ power (BW2/3) to approximate the expression of
dose in terms of surface area of the target organ (represented as a
perfect sphere), with exposure defined in mg of contaminant/(body
weight)2/3/day 4. This approach is based on the
assumption that equivalent doses between animal species can be
expressed in terms of mg/surface area/day (Mantel and Schneiderman,
1975). This assumption is more appropriate at low applied-dose
concentrations where sources of nonlinearity, such as saturation or
induction of enzyme activity, are less likely to occur.
---------------------------------------------------------------------------
\43\ The specific equation for converting an animal dose to a
human equivalent dose using the BW2/3 scaling factor is:
Human Equivalent Dose (mg/kg-day) = Animal Dose (mg/kg-day) x
Animal BW Animal BW2/3 x Human
BW2/3 Human BW
that is equivalent to
Animal Dose Animal BW Human BW1/3
---------------------------------------------------------------------------
The estimation of cancer risk to humans typically used animal
bioassay data extrapolated to low doses approximating human exposure
using the LMS. The LMS model was fit to tumor data using a computer
program (e.g., GLOBAL 86) that calculated the 95th percentile upper
confidence limit on the linear slope in the low-dose range. The slope
that is obtained is referred to as the q1*, and was used as
an estimate of cancer potency. When animal data are used for these
calculations, the body weights are scaled using BW2/3, as
discussed above. The q1* values obtained using the LMS model
and slope factors derived from other models were expressed in the form
of x (mg/kg-day) -1 and are often used to estimate the upper
bound of the
[[Page 43777]]
lifetime cancer risk for long-term low- level exposure to agents.
Upper-bound risk assessments carried out with the low-dose linear
model were generally considered conservative, representing the most
plausible 95th percentile upper bound for risk. The ``true risk'' was
considered unlikely to exceed the risk estimate derived by this
procedure, and could be as low as zero at low doses. The use of low-
dose linear extrapolation with a default to LMS was endorsed by four
agencies in the Interagency Regulatory Liaison Group and was
characterized as less likely to underestimate risk at the low doses
typical of environmental exposure than other models and approaches that
were available. Because of the uncertainties associated with
extrapolation from high to low dose and from animals to humans, assumed
water and fish exposure, and the serious public health consequences
that could result if risk were underestimated, EPA believed that it was
prudent to use the LMS to estimate cancer risk for the AWQC. In
deriving water quality criteria, the slope factors are currently
estimated using the LMS model under most circumstances.
Basic assumptions that are used to calculate the AWQC include a
daily consumption rate of 2 liters of water per day (from all sources),
a daily fish consumption rate of 6.5 grams per day, and a body weight
of 70 kilograms (kg) (154 pounds). The maximum lifetime cancer risk
generated by waterborne exposure to the agent is targeted in the range
of one in one hundred thousand to one in ten million (10-5
to 10-7). The formula for deriving the AWQC in mg/L for
carcinogens presented in the 1980 AWQC National Guidelines is:
where:
10-6=target cancer risk level; the 1980 AWQC National
Guidelines recommended risk levels in the range of 10-5 to
10-7
[GRAPHIC] [TIFF OMITTED] TN14AU98.007
70=assumed body weight of an adult human being (kg)
q1*=carcinogenic potency factor for humans derived from LMS
model (mg/kg-day)-1
2=assumed daily water consumption of an adult human (L/day)
0.0065=assumed daily consumption of fish (kg)
R=bioconcentration factor (L/kg) from water to food (e.g., fish, birds)
(b) 1986 EPA Guidelines for Carcinogenic Risk Assessment. Since
1980, EPA risk assessment practices have evolved significantly. In
September 1986, EPA published its Guidelines for Carcinogen Risk
Assessment (referred to subsequently in this document as the 1986
Cancer Guidelines) in the Federal Register (51 FR 33992) (USEPA, 1986).
The 1986 Cancer Guidelines were based on the publication by the Office
of Science and Technology Policy (OSTP, 1985) that provided a summary
of the state of knowledge in the field of carcinogenesis and a
statement of broad scientific principles of carcinogen risk assessment
on behalf of the Federal government. The 1986 Cancer Guidelines
categorize chemicals into alpha-numerical groups: A (known human
carcinogen; sufficient evidence from epidemiological studies or other
human studies); B (probable human carcinogen; sufficient evidence in
animals and limited or inadequate evidence in humans); C (possible
human carcinogen; limited evidence of carcinogenicity in animals in the
absence of human data); D (not classifiable; inadequate or no animal
evidence of carcinogenicity); and E (no evidence of carcinogenicity in
at least two adequate species or in both epidemiological and animal
studies). Within Group B there are two subgroups, Groups B1 and B2.
Group B1 is reserved for agents for which there is limited evidence of
carcinogenicity from epidemiological studies. It is reasonable, for
practical purposes, to regard an agent for which there is
``sufficient'' evidence of carcinogenicity in animals as if it
presented a carcinogenic risk to humans. Therefore, agents for which
there is ``sufficient evidence'' from animal studies and for which
there is ``inadequate evidence'' or ``no data'' from epidemiological
studies would usually be categorized under Group B2 (USEPA, 1986). The
system was similar to that used by the International Agency for
Research on Cancer (IARC).
The 1986 Cancer Guidelines include guidance on what constitutes
sufficient, limited, or inadequate evidence. In epidemiological
studies, sufficient evidence indicates a causal relationship between
the agent and human cancer; limited evidence indicates that a causal
relationship is credible, but that alternative explanations, such as
chance, bias, or confounding, could not adequately be excluded;
inadequate evidence indicates either lack of pertinent data, or a
causal interpretation is not credible. In animal studies, sufficient
evidence includes an increased incidence of malignant tumors or
combined malignant and benign tumors:
(a) In multiple species or strains;
(b) In multiple experiments (e.g., with different routes of
administration or using different dose levels);
(c) To an unusual degree in a single experiment with regard to high
incidence, unusual site or type of tumor, or early age at onset;
(d) Additional data on dose-response; short-term tests or
structural activity relationship.
Limited evidence includes studies involving a single species,
strain, or experiment which do not meet criteria for sufficient
evidence; experiments restricted by inadequate dosage levels,
inadequate duration of exposure, inadequate period of follow-up, poor
survival, too few animals, or inadequate reporting; an increase in
benign but not malignant tumors with an agent showing no response in a
variety of short-term tests for mutagenicity; or responses of marginal
statistical significance in a tissue known to have a high or variable
background rate.
In the 1986 Cancer Guidelines, hazard identification and the
weight-of-evidence process focus on tumor findings. The human
carcinogenic potential of agents is characterized by a six-category
alphanumeric classification system. The weight-of-evidence approach for
making judgment about cancer hazard analyzes human and animal tumor
data separately, then combines them to make the overall conclusion
about potential human carcinogenicity. The next step of the hazard
analysis is an evaluation of supporting evidence (e.g., mutagenicity,
cell transformation) to determine whether the overall weight-of-
evidence conclusion should be modified.
For cancer risk quantification, the 1986 Cancer Guidelines
recommend the use of LMS as the only default approach. The 1986 Cancer
Guidelines also mention that a low-dose extrapolation model other than
the LMS might be considered more appropriate based on biological
grounds. However, no guidance was given in choosing
[[Page 43778]]
other approaches. The 1986 Cancer Guidelines continued to recommend the
use of (BW) 2/3 as a dose scaling factor between species.
(c) Scientific Issues Associated with the Current Cancer Risk
Assessment Methodology for the Development of AWQC. In reviewing the
current approach for the development of Water Quality Criteria for
Human Health, EPA feels that the alphanumeric classification scheme for
carcinogens adopted in 1986 was too rigid and relied too heavily on
tumor findings and the full use of all relevant information, an
understanding of how the agent induces tumors, and the relevance of the
mode of action to humans was not promoted. Because guidance was not
provided in the 1986 Cancer Guidelines for developing a mode of action
understanding about how the agent induces tumors, dose-response
assessments have been traditionally based on the modeling of tumor data
with the LMS approach. There is an increasing number of examples of
where the use of linear extrapolation may not be appropriate (e.g.,
nonmutagenic carcinogens causing a hormonal imbalance and thyroid gland
neoplasia, or inducing bladder tumors secondary to bladder calculi-
induced hyperplasia). Additionally, the circumstances or conditions
under which a particular hazard is expressed (e.g., route, duration,
pattern, or magnitude of exposure) are not conveyed with the 1986
letter classification system.
The Office of
This text is long and has been trimmed here. Open the source document for the complete record.
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.